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CHAPTER I 
 
INTRODUCTION 
 
Overview of Chronic Abdominal Pain (CAP) 
Abdominal pain is the most common chronic pain complaint reported in 
childhood (McGrath, 1990) and is one of the most common reasons for referral to 
pediatric primary care providers (Starfield et al., 1980).  Chronic abdominal pain (CAP) 
is defined as at least three episodes of abdominal pain severe enough to interrupt 
activities over a period of at least three months (Apley, 1975).  CAP is a description of 
symptoms rather than a diagnosis (von Baeyer & Walker, 1999).  Children with CAP 
exhibit high levels of somatic symptoms, anxiety and depressive symptoms, functional 
impairment, and health service use at the time of initial presentation (e.g. Garber, Zeman, 
& Walker, 1990; Lipani & Walker, 2006; L. S. Walker, Garber, Smith, van Slyke, & 
Claar, 2001) Medical evaluations typically do not indicate any identifiable organic illness 
(Dorn et al., 2003; L. S. Walker, et al., 2001; L. S. Walker, Garber, van Slyke, & Greene, 
1995; L. S. Walker, Guite, Duke, Barnard, & Greene, 1998).   
Several studies support the idea that the pattern of CAP and related symptoms can 
continue into adolescence and adulthood (Mulvaney, Lambert, Garber, & Walker, 2006; 
L. S. Walker, et al., 1995; L. S. Walker, et al., 1998; L. S. Walker & Heflinger, 1998).  
Participants with CAP and no identifiable organic diagnosis showed increased somatic 
symptoms, abdominal pain, and depressive symptoms when compared to well control 
group participants five years after initial evaluation (L. S. Walker, et al., 1995; L. S. 
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Walker, et al., 1998; L. S. Walker & Heflinger, 1998).  A recent longitudinal study 
(Mulvaney, et al., 2006) demonstrated three distinct trajectories of symptoms and 
functional impairment at follow-up.  Both low risk and short-term risk groups showed 
little elevation in symptoms and functional impairment five years after the clinic visit.  
However, a long-term risk group that represented 14% of the sample maintained 
significant levels of symptoms and functional impairment commensurate with initial 
reported levels.  Thus, there is a need to further understand what contributes to symptom 
maintenance and functional impairment and the relation of psychological variables to 
outcomes in order to improve treatment and consequently long-term outcomes for CAP 
patients.   
 
Contemporary Theories of Pain 
 The modern definition of pain is: “An unpleasant sensory and emotional 
experience associated with actual or potential tissue damage, or described in terms of 
such damage”("IASP Pain Terminology:  Pain," 2008). Until the 1950’s, theories of pain 
held that the psychological experience of pain was commensurate with the severity of the 
injury or damage, meaning that pain needed to involve tissue damage.  The brain was 
constrained to the role of recipient of the peripheral signals of pain; thus individuals who 
endorsed pain without having clear organic damage were seen as having psychological 
impairment (Melzack & Katz, 2004).   
Gate control theory (Melzack & Wall, 1965), one of the earlier theories involving 
the brain’s role in pain, was proposed in 1965 and by the mid 1970’s the theory was 
widely cited in medical text books.  It is the foundation for current understanding of the 
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mechanisms of pain and pain perception (Melzack & Katz, 2004) and has inspired 
numerous clinical applications aimed at controlling pain (Novy, Nelson, Francis, & Turk, 
1995).  Gate control theory asserts that the signals sent from the periphery to the 
receptors on the spinal cord are modulated by inputs from the gate control system.  These 
inputs sent from the gate control system are influenced by signals sent from the brain; 
thus, the brain has an influential role in how peripheral signals are interpreted and 
consequently one’s experience of pain (Melzack & Katz, 2004).  
 It is important to recognize the role of the brain in the pain experience if we are to 
understand how the pain process works generally and specifically in individuals both 
with and without evidence of organic etiology for their pain.  Research examining the 
experience of phantom limb pain has demonstrated that the brain is not a passive 
recipient of sensory inputs from the periphery (Hadjistravropoulos & Craig, 2004), but 
rather the brain generates sensory experience and the inputs from sensory neurons 
modulate the experience (Melzack & Katz, 2004).  The importance of the brain in pain 
suggests that interventions should be aimed not just at the site of the injury, but also at the 
higher levels of the brain involved in perception (Melzack & Katz, 2004).  The 
importance of the brain in the pain process also suggests that interventions aimed at 
cognitions, also a product of the brain, may impact one’s experience of pain.      
 Psychology’s role in the understanding and treatment of pain has been increasing 
since the introduction of the gate control theory of pain.  Hadjistravropoulos and Craig 
(2004) emphasize the importance of psychological research and understanding in the 
field of pain.  In the past, pain has been viewed from a dualistic model where it was seen 
as either entirely related to tissue damage or entirely in one’s head and related to 
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psychological illness (Hadjistravropoulos & Craig, 2004).  Those theories which focused 
only on psychological or biological causes of pain have been classified as restrictive 
(Novy, et al., 1995).  Both restrictive views separated the mind from the body.  Current 
conceptions of pain, including the gate control theory, embrace the mind-body 
connection.  Theories that include both psychological and biological components have 
been classified as comprehensive and include gate control theory, nonradical operant 
behavioral theory, and cognitive behavioral theory (Novy, et al., 1995).  Currently, the 
influences of physiological damage as well as cognitions, behavior, affect, and social 
factors are recognized in comprehensive theories of pain (Asmundson & Wright, 2004) 
both in adults and in children (Bush & DeLuca, 2001; Zeltzer, Tsao, Bursch, & Myers, 
2006).   
 Several models incorporating biopsychosocial elements have been proposed 
(Asmundson & Wright, 2004).  The operant model asserts that illness behavior is initially 
reinforced by the reduction in pain and then maintained by the addition of positive 
reinforcers such as social attention or negative reinforcers such as decreases in demands 
placed on the individual.  The Glasgow model proposes that the interaction of biological 
and psychological factors can lead to illness behavior and that physical pathology is an 
important precipitant.  The biobehavioral model suggests that a diathesis-stress 
interaction is responsible for the development of persistent pain and disability where the 
diathesis is a predisposition to a lower pain threshold.  The fear-avoidance model asserts 
that the appraisal of pain as a threat results in avoidance and subsequent disability 
whereas an appraisal of pain as non-threatening allows one to confront the pain, leading 
to recovery.  Asmundson and Wright (2004) suggest an integrated diathesis-stress model 
5 
 
resulting from their review of the above models.  This integrated model suggests that 
some individuals have a diathesis to respond to pain with an appraisal that the pain is a 
threat thus leading to anxiety and apprehension, then avoidance and disability.  This 
pattern cycles back onto itself and is moderated by social influences as well as 
vulnerability factors.        
 Contemporary theories of pain suggest that biological, cognitive, affective, 
behavioral, and social variables affect both the experience of pain and the maintenance or 
cessation of pain.  Persistent pain has also been shown to have consequences on one’s 
functioning in life (Asmundson & Wright, 2004) and can lead to pain associated 
disability syndrome (Zeltzer, et al., 2006).  Interventions for chronic pain thus often seek 
to reduce difficulties in functioning, both physically and emotionally (Ashburn & Staats, 
1999; Turk et al., 2003).   
 
Self-Efficacy 
 
Definition 
Research on the construct of self-efficacy began in the 1970’s and since that time 
has expanded greatly (DeVellis & DeVellis, 2001; J. Walker, 2001).  Self-efficacy is 
defined as “beliefs in one’s capabilities to organize and execute the courses of action 
required to produce given attainments” (Bandura, 1997, p. 3).  Self-efficacy is a major 
component of social cognitive theory and originally grew out of social learning theory, 
which is grounded in operant conditioning principles.  Operant conditioning states that 
behaviors are determined by their consequences.  Rotter expanded these principles to 
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social behavior when he developed social learning theory.  Bandura also developed a 
separate social learning theory, later known as social cognitive theory.  Social learning 
theory purports that the value people put on an outcome and the expectancy that the 
behavior will result in the outcome are the two major determinants of behavior (DeVellis 
& DeVellis, 2001).  Thus, if people believe a behavior will produce a valued outcome, 
they are likely to execute the behavior.         
Rotter also introduced the concept of locus of control pertaining to belief about 
whether an outcome is under one’s control or under the control of an external entity 
(DeVellis & DeVellis, 2001).  Though self-efficacy grew out of the locus of control 
literature, they are separate constructs.  People’s understanding of their control in a 
situation can have differing effects on their self-efficacy, depending on whether they feel 
talented in handling that situation.  If they do not feel capable and feel they have control 
they will have low self-efficacy (Bandura, 1977a).  Conversely, one may have self-
efficacy for an action but not believe this will have any effect on an outcome such as their 
health and would then have high self-efficacy but low internal locus of control (Ewart, 
2004).  However, the belief about causality ascribed to a particular behavior, either skill 
or chance, can mediate the resulting effects of the behavioral outcome on later 
perceptions of self-efficacy (Bandura, 1977a).  Social cognitive theory purports that three 
major factors (personal, behavioral, and environmental) influence each other and 
resulting human agency (Ewart, 2004).  Bandura’s social cognitive theory differed from 
Rotter’s social learning theory as it included imitation as a means of learning and he later 
developed the construct of self-efficacy; however, Kirsch (1985) has challenged the 
uniqueness of Bandura’s construct of self-efficacy.   
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The construct of self-efficacy refers to people’s beliefs about their capabilities, 
whereas traditional social learning theory focuses on outcome expectancies or people’s 
beliefs about locus of control and the relation between behavior and outcome (Bandura, 
1977a; DeVellis & DeVellis, 2001).  Thus, self-efficacy is not about whether an outcome 
will happen but whether people believe they are able to perform the behavior thought to 
lead to that outcome (Bandura, 1977b).  While self-efficacy has been shown to predict 
outcomes, its ability to predict outcomes is not related to the theoretical underpinnings of 
the construct of self-efficacy.  The actual achievement of the outcome is not the focus in 
self-efficacy.  Rather, people’s perception that they can perform the behavior necessary 
for the outcome is the emphasis of self-efficacy.  The behavior is not simply the subset of 
skills, but also the coordination of these skills into the necessary coordinated behavior 
(Bandura, 1997; DeVellis & DeVellis, 2001).   
People’s ratings of their self-efficacy are typically defined in relation to a fairly 
specific task or domain.  It follows that self-efficacy is not a trait but rather varies within 
specific contexts (DeVellis & DeVellis, 2001).  For example, one might feel efficacious 
about her ability to cook a gourmet meal but feel inefficacious about singing an opera or 
even something in a similar domain such as baking a wedding cake.  However, when 
self-efficacy increases in one behavioral domain, self-efficacy in other domains, 
particularly similar ones, often increases (Bandura, 1977a).  Some researchers suggest 
that self-efficacy does not have to be measured in reference to very specific tasks and that 
while there is not a generalized self-efficacy, it is useful to combine across tasks or 
dimensions and use a total self-efficacy score in research (Levin, Lofland, Cassisi, Poreh, 
& Blonsky, 1996).  There is some disagreement about this in the literature, especially 
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regarding the utility of using a more generalized self-efficacy for research versus its 
clinical utility.  Self-efficacy research across domains demonstrates that self-efficacy 
significantly affects one’s motivation and psycho-social functioning (O'Leary, 1985).  
Self-efficacy theory is concerned with the effects of people’s perceptions of their 
capabilities and how these self-perceptions affect behavior, motivation, thoughts, and 
emotions (O'Leary, 1985).  It is theorized that one can have self-efficacy for coping with 
a stressor, either in an active or accommodative manner.  One’s perception that she can 
cope in a given situation will influence whether the attempt to cope is undertaken 
(Bandura, 1977a).  If one has high self-efficacy regarding a behavior, she will persist 
longer and make stronger efforts toward accomplishing this behavior, even in the context 
of an aversive stressor.  However, one’s expectation that she can handle something will 
not necessarily produce the desired outcome as she has to have the necessary ability to 
perform the behavior (Bandura, 1977a).  
Self-efficacy (Keefe, Rumble, Scipio, Giordano, & Perri, 2004) is associated with 
improved outcomes and is an important contributor to current understandings of 
associations between psychological factors and chronic pain.  Self-efficacy is a 
hypothetical construct (Chronbach & Meehl, 1955; Garber & Strassberg, 1991), meaning 
that it is an hypothesized process or attribute that cannot be directly observed.  In the 
context of chronic pain, self-efficacy can be defined as a belief about one’s ability to 
perform specific tasks despite pain and to cope while in pain (Nicholas, 2007).  Self-
efficacy has received extensive attention both in the general psychological literature as 
well as in pain specific literature, particularly in relation to functioning while in pain.   
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Self Efficacy and Pain 
While Bandura’s (1977a) research speaks largely to self-efficacy’s key role in 
phobias—fearful and avoidant contexts—the theory can be applied to contexts of pain 
where people are often fearful or avoidant of behaviors that may cause increased pain.  
There are two ways that the construct of self-efficacy has been conceptualized in the 
context of chronic pain.  Some investigators view self-efficacy in the context of chronic 
pain as people’s beliefs that they can function, by performing specific behaviors, and 
cope emotionally despite the pain (functional self-efficacy) (e.g., Lackner & Carosella, 
1999; Nicholas, 2007), whereas others view it as people’s beliefs that they can alleviate 
pain (pain self-efficacy) (Anderson, Dowds, Pelletz, Edwards, & Peeters-Asdourian, 
1995).   
Bandura combines both of these versions of self-efficacy stating that perceived 
self-efficacy relates both to people’s judgments about their ability to do certain behaviors 
as well as to their ability to assert control over situations (Bandura, O'Leary, Taylor, 
Gauthier, & Gossar, 1987).  The pain literature includes studies that conceptualize self-
efficacy in both of these ways.  The majority of studies examining the relation between 
self-efficacy and functioning in the context of pain conceptualize self-efficacy as 
people’s beliefs that they can perform specific or general behaviors despite the pain 
(functional self-efficacy), rather than as people’s beliefs that they can alleviate the pain 
(pain self-efficacy) (e.g., Chong, Cogan, Randolph, & Racz, 2001; Estlander, 
Vanharanta, Moneta, & Kaivanto, 1994; Kaivanto, Estlander, Moneta, & H., 1995; 
Nicholas, 2007).  Lackner, Carosella, & Feuerstein (1996) report that functional self-
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efficacy is more predictive of physical performance in those with lower back pain than is 
pain specific self-efficacy.             
Higher levels of pain self-efficacy and functional self-efficacy have related to 
better functional outcomes.  Arnstein (2000) states that self-efficacy is typically 
conceptualized as a mediator, a mechanism that explains how chronic pain leads to 
disability.  When self-efficacy is described as a mediator between pain intensity and 
disability (Arnstein, 2000; Arnstein, Caudill, Mandle, Norris, & Beasley, 1999; Costa, 
Maher, McAuley, Hancock, & Smeets, 2011) it aids our understanding of how pain leads 
to problems in functioning.  Bandura (1987) explains that self-efficacy may divert 
attention away from pain by allowing one to focus on other tasks at hand rather than 
focusing solely on the pain.  Thus, when one engages in activities, it may foster 
distraction that in turn reduces one’s perception of pain.  Those with pain may find that 
when they increase their activity, pain does not necessarily increase and may actually 
decrease (Arnstein, 2000), potentially by the mechanism described above by Bandura 
(1987).  Mediation models support the idea that when people live with chronic pain, their 
self-efficacy for their ability to function may lead to actual increases in functioning 
(Arnstein, 2000). 
Successful management of chronic pain does not necessarily mean getting rid of 
the pain.  Rather, interventions are often aimed at increasing levels of psychological and 
physical functioning in spite of pain (Ashburn & Staats, 1999).  Turk et al. (2003, p. 342) 
state that while pain levels should be managed where possible, care should also be aimed 
at improving “physical functioning, emotional functioning, participant ratings of global 
improvement and satisfaction with treatment, symptoms and adverse events, and 
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participant disposition”.  The authors specifically mention both physical and emotional 
functioning and note that pain levels and functioning levels are only modestly related in 
many studies and thus pain reduction should not be the only outcome of interest in pain 
intervention and research.  Thus, people’s belief in their ability to function in the 
presence of pain, functional self-efficacy, is as important as their belief that they can 
reduce the pain.     
 
Self-Efficacy—Relation to Pain, Physical, and Psychological Functioning   
Psychosocial factors, including self-efficacy, help predict disability from chronic 
pain beyond disability predicted by pain levels (Arnstein, 2000; Costa, et al., 2011).  
Disability resulting from chronic pain can include loss of work time and inability to 
perform everyday activities.  Functioning is the absence of disability and the ability to 
carry-on every day and perform meaningful behaviors.  Self-efficacy has been found to 
be a predictor of disability in a variety of chronic pain populations (e.g. musculoskeletal 
(Denison, Asenlof, & Lindberg, 2004), fibromyalgia (Buckelew, Murray, Hewett, 
Johnson, & Huyser, 1995), and lower back pain (Anderson, et al., 1995; Ayre & Tyson, 
2001; Costa, et al., 2011; Lackner, et al., 1996; Levin, et al., 1996)).  Self-efficacy has 
been studied in a variety of settings including pain clinics (Anderson, et al., 1995; 
Masedo & Esteve, 2007; Meredith, Strong, & Feeney, 2006) and primary care clinics 
(Barry, Guo, Kerns, Duong, & Reid, 2003; Denison, et al., 2004).   
Perceived self-efficacy can effect functioning in numerous ways.  It influences 
which activities are attempted, how much effort will be put forward, the length of 
persistence at an activity when challenges arise, and adherence to treatment regimens 
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(Bandura, 1977a; O'Leary, 1985).  A literature review on physical functioning in pain 
patients briefly discusses the importance of self-efficacy in predicting performance on 
physical tasks (Geisser, Robinson, Miller, & Bade, 2003).  Self-efficacy was the strongest 
predictor of both pain and physical activity included in this study.  Self-efficacy in 
relation to pain has been found to correlate strongly with several important variables 
including disability, pain intensity, depression, work status, and catastrophizing (Denison, 
et al., 2004; Rahman, Reed, Underwood, Shipley, & Omar, 2008).  Self-efficacy is 
inversely related to measures of pain throughout the literature (e.g.,  Buckelew, et al., 
1995; Chong, et al., 2001).  These relations point to the importance of knowing how these 
variables interact in the presence of pain.       
There is strong support, across a variety of pain populations, for the importance of 
self-efficacy in aiding our understanding of pain and improving functional adjustment to 
pain (Ayre & Tyson, 2001; Borsbo, Gerdle, & Peolsson, 2010; Buckelew, et al., 1995; 
Denison, et al., 2004; Estlander, et al., 1994; Kaivanto, et al., 1995).  In a highly cited 
article (Arnstein, 2000), self-efficacy1 was shown to strongly2 mediate the relation 
between disability and pain intensity using path analytic strategies.  Self-efficacy 
accounted for more of the variance in disability than did pain intensity in two of the three 
samples included in the study (Arnstein, 2000).  In a study examining people in a 
rehabilitation program for their chronic pain, functional self-efficacy3
                                               
1 Self-efficacy refers to a total self-efficacy in the context of chronic pain that includes functional self-
efficacy but is not limited to only functional self-efficacy and includes other self-efficacy subscales, such as 
pain self-efficacy.    
 was once again 
shown to be a stronger predictor of disability than pain intensity (Meredith, et al., 2006).  
2 In this review the following scale is used in order to designate the strength of Pearson correlations:  .1-
.3=weak, .3-.5=moderate, .5-.7=strong (Hopkins, 2002). 
3 The term functional self-efficacy is used when the study examined the functional self-efficacy in isolation, 
rather than as part of a larger self-efficacy scale.   
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In back pain patients, functional self-efficacy accounted for a significant amount of the 
variance in physical disability levels, even after pain levels were controlled (Ayre & 
Tyson, 2001).  In a recent longitudinal study of patients with low back pain (Costa, et al., 
2011), functional self-efficacy was a predictor of the level of disability at a 12-month 
follow-up and mediated the influence of pain, whereas pain catastrophizing was not a 
significant mediator for the 12-month disability levels.  The construct of functional self-
efficacy moderately relates to functional disability after pain levels have been taken into 
account.    
A review of the literature shows that when compared with other predictive 
variables, functional self-efficacy consistently remains one of the strongest predictors of 
disability.  Across various chronic pain populations, ages, scales, functioning levels, and 
multiple countries, functional self-efficacy relates to both physical and psychological 
functioning as well as pain levels.  In some cases functional self-efficacy has even shown 
greater utility in predicting disability than has pain levels (e.g., Estlander, et al., 1994; 
Kaivanto, et al., 1995) and functional self-efficacy has shown unique contributions 
beyond self-report disability measures (Kaivanto, et al., 1995).         
Only two of the studies that examined the relation between pain self-efficacy and 
disability or functioning in the context of chronic pain were longitudinal in design 
(Barlow, Cullen, & Rowe, 2002; Costa, et al., 2011) and one (Barlow, et al., 2002) did 
not measure self-efficacy at the baseline, but rather only at follow-up.  Therefore, most 
studies cannot draw conclusive causal inferences.  In a two sample study looking at 
musculoskeletal pain patients in a primary care setting, self-efficacy was the strongest 
predictor (24% and 21% of variance) of functioning when all other variables were 
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controlled (Denison, et al., 2004).  Fear avoidance accounted for a small (7% and 6% of 
variance) though significant amount of the variance when all other variables were 
controlled.  However, the measures of disability and self-efficacy were fairly similar as 
they both focused on the completion of certain tasks (interference and confidence 
respectively) and the study was cross-sectional.   
While many studies have examined the role of self-efficacy in relation to other 
variables such as coping, anxiety, and depression in the context of chronic pain in adults, 
very few studies have looked at the role of self-efficacy on anxiety and depression in 
children with pain, particularly not those with chronic abdominal pain (Kaminsky, 
Robertson, & Dewey, 2006).  In a study including children, child and parent reports of 
functional self-efficacy were not significantly related to child reports of physical or 
psychological functioning (Bursch, Tsao, Meldrum, & Zeltzer, 2006).  Parent and child 
reports of children’s high functional self-efficacy related to parent reports of increased 
physical functioning and mental health, but not to parent reported pain levels (Bursch, et 
al., 2006).  When looking at recurrent abdominal pain in children, Kaminsky et al. (2006) 
found that greater depressive symptoms are significantly related to lower levels of self-
efficacy when controlling for pain levels; however, no analyses examined the relations 
between self-efficacy and functioning or how health locus of control and self-efficacy are 
related or if self-efficacy levels varied by age in pediatric populations.  Thus, there is 
ample room for further study into the role of self-efficacy in pediatric chronic pain 
populations. 
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In general, these findings suggest that pain-related4
The type of chronic pain has varied widely across studies, often even within the 
same study.  Some types of pain are known to be caused by underlying organic disease 
(e.g. rheumatoid arthritis) while the etiology of others is less known (e.g. fibromyalgia).  
The impact of either pain self-efficacy or functional self-efficacy on functioning may 
vary depending on the type of pain or on whether there are means of sufficiently 
alleviating pain.  Some pain conditions may have more treatments available that can 
alleviate the pain.  Using participants with one pain disorder, comparing individuals with 
distinct types of pain, or controlling for type of pain will be important in future research.   
 self-efficacy is a key 
component in understanding the relation between pain and disability and suggest that 
people may become disabled from chronic pain, in part, because of their low self-efficacy 
or lack of belief in their abilities (Arnstein, 2000).  Increased functioning due to higher 
self-efficacy may be a similar process to increased functioning because of the placebo 
effect.  People feel more confident that they can perform a task, either because of their 
own resources or those provided by the “medicine” (placebo), and they consequently 
have a higher level of functioning (O'Leary, 1985).  It may also be that people with high 
functional self-efficacy catastrophize less and thus have less negative outcome 
expectancies of performing a given task (Lackner, et al., 1996).   
A review of the literature (Marks, 2001) examined articles applying self-efficacy 
theory to interventions aimed at improving arthritis management.  Most of the studies 
demonstrated either improvements in self-efficacy or improvements in arthritis 
management and pain levels following an intervention.  However, some studies did not 
                                               
4 The term pain-related self-efficacy is used to simultaneously encompass both types of self-efficacy that 
occur in the pain literature:  pain self-efficacy and functional self-efficacy 
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show improvements across the board.  One showed improvements in one type of self-
efficacy (pain) while not in another type (functioning).  Marks (2001) points to the 
importance of improving self-efficacy and its ability to enhance arthritis management as 
well as psychological well-being.  He also states that it is still unclear whether improving 
self-efficacy will change functioning.  The ability of psychological intervention to 
manipulate self-efficacy increases the importance of understanding self-efficacy’s 
development and impact on outcomes.  By manipulating self-efficacy, we may be able to 
improve physical and psychological functioning, though this is still an area needing 
further research.  Thus, there are applied as well as theoretical benefits to greater study of 
the development of pain-related self-efficacy.           
Self-efficacy in the context of chronic pain, both pain self-efficacy and functional 
self-efficacy, relates to better physical and psychological outcomes.  However, no studies 
were found that examine pain-related self-efficacy longitudinally and its relation to 
longitudinal outcomes or how it changes across time.  Longitudinal studies are needed in 
order to provide a clearer picture of the process by which pain, physical and 
psychological functioning, and pain-related self-efficacy relate to each other across time 
and development.   
 
Development of Self-Efficacy 
Relatively little is known about the development of self-efficacy across time and 
ages.  Very few studies have examined longitudinal changes in self-efficacy levels in any 
subject domain.  No studies of pain-related self-efficacy were found that included 
longitudinal assessment of change in self-efficacy.   
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 Bandura (1977a) lists four factors that influence the development of self-efficacy: 
performance accomplishments, vicarious experiences, verbal persuasion, and 
physiological states.  More recently (Bandura, 2004), he has added that social support 
also has the ability to increase one’s coping efficacy, but if it is offered in a way that 
increases dependence on others rather than belief in one’s self, then social support can 
lead to declines in self-efficacy.  Limited research has examined what factors contribute 
to long-term increases in self-efficacy and to what outcomes changes in self-efficacy are 
related.  
 A few studies have examined change in self-efficacy from one time point to 
another where interventions were not used.  Some of the variables predicting change in 
self-efficacy were domain specific and generalizations to pain-related self-efficacy are 
difficult because of the domain and task specific nature of self-efficacy.  A study of 
changes in smoking self-efficacy (Carey & Carey, 1993) found that those who quit 
showed increases in self-efficacy, while those who quit and then relapsed or were never 
able to quit showed decreases in self-efficacy.  Participants in a study examining changes 
in self-efficacy for refraining from behavior related to HIV risk showed three patterns of 
change: increased, stable, and decreased self-efficacy (Kang, Deren, Andia, Colon, & 
Robles, 2004).  The authors did not report what, if any, factors related to membership in 
these three groups.  A study looking at changes in self-efficacy in engineering students 
produced a model showing that self-efficacy predicted changes in other variables, but 
none of the predictor variables (outcome expectancies, goals, interests) predicted changes 
in self-efficacy (Lent et al., 2008).  Self-efficacy for self-regulated learning decreased for 
students from junior to senior year, especially for males (Caprara et al., 2008).  Overall, it 
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appears that experiencing success in a specific domain typically leads to increases in self-
efficacy in that domain; however, generally, both the pain and the larger self-efficacy 
literature is very limited and provides no clear pattern regarding the development of self-
efficacy.                  
 
Gender 
The impact of gender on the development of self-efficacy beliefs appears to be 
context dependent on the type of self-efficacy studied; however, it appears that while 
females tend to begin with lower levels of self-efficacy, these levels increase over 
development.  In a study of adolescence transitioning to young adults in college, girls 
reported lower initial levels of science self-efficacy (Larose, Ratelle, Guay, Senecal, & 
Harvey, 2006); however, girls were more likely to show increased science self-efficacy 
over the course of the study.  In young adolescents, females exhibit significantly higher 
academic self-efficacy, but significantly lower social self-efficacy than boys (Bandura, 
Pastorelli, Barbaranelli, & Caprara, 1999).  Longitudinally, adult females with alcohol 
use disorders showed greater increases in alcohol-related self-efficacy over the course of 
16 years than did males (McKellar, Ilgen, Moos, & Moos, 2008).     
Pain-related self-efficacy does not show a consistent relation to gender cross-
sectionally and has not been studied longitudinally.  In a study of adults, group 
membership in high or low pain-related self-efficacy groups was not influenced by 
gender or age; however, this study was not longitudinal and did not examine changes in 
self-efficacy (Denison, Asenlof, Sandborgh, & Lindberg, 2007).  Gender was not related 
to child or parent reported pain-related self-efficacy in a study of children with chronic 
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pain (Bursch, et al., 2006); again, this was not longitudinal and did not look at changes in 
self-efficacy.  Another study of children and adolescents (Vierhaus, Lohaus, & Schmitz, 
2010) using a constructed pain-related self-efficacy scale that appears similar to emotion-
focused coping potential found that boys had higher self-efficacy levels and that self-
efficacy mediated the relation between sex and experimental pain ratings.  Chong et al. 
(2001) reports discrepancies in the literature examining cross-sectional relations of pain-
related self-efficacy and gender with some studies indicating higher self-efficacy in males 
while others show no differences.  Their study resulted in no significant differences in 
pain-related self-efficacy based on gender.          
 
Age 
There is little consistency in the relation between age and self-efficacy across 
various studies covering several different types of self-efficacy.  Across all domains, self-
efficacy appraisals will change across development because the contingencies upon 
which they are based fluctuate with age (Cervone, Artistico, & Berry, 2006).  For 
instance, in relation to pain, one’s access to coping means such as medication or social 
support may vary with age and consequently so would one’s self-efficacy for these 
behaviors.  In a study examining changes in physical self-efficacy in pre-adolescents (8-
12 years old) after a physical activity intervention, no age differences were found.  The 
author (Annesi, 2007) concluded that there were no differences in self-efficacy change 
based on age or based on Piaget’s developmental stages; however, this study used age by 
time interactions in regressions rather than examining changes in slope via multilevel 
modeling.  A longitudinal study of children (6-18 years old) found that self-efficacy 
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beliefs regarding aggression and achievement were more predictive of behavior for older 
children than for younger children.  (Davis-Kean et al., 2008).           
The literature on pain-related self-efficacy reports little information about the 
relation between age and self-efficacy.  The age ranges in the studies are typically very 
large including young adults and the elderly, making focused questions regarding age 
challenging.  One study of pain-related self-efficacy (Chong, et al., 2001) found that self-
efficacy was lower in young adults (17-35 years of age) than in middle aged adults (36 to 
55 years of age) in participants with various pain types (Chong, et al., 2001).  Chong et 
al. commented in their discussion that their findings indicate that the youngest pain group 
could benefit the most from enhancing their self-efficacy, forgetting that those under the 
age of 17 are in an even younger age group.  Group membership as high or low pain-
related self-efficacy was not influenced by age in a study of patients with musculoskeletal 
pain (Denison, et al., 2007).  In a study of children with chronic pain (Bursch, et al., 
2006), no relation was found between child and parent reported self-efficacy and age.  No 
study examined the change in self-efficacy and its relation to age.  Thus, there is need to 
understand what, if any, differences exist in pain-related self-efficacy across the 
developmental continuum and how this impacts how we deliver interventions to patients 
of various ages.     
Examining developmental differences by including both children and adults 
would help to bridge the gap in our current knowledge, given the limited information on 
developmental differences in self-efficacy in adults (Chong, et al., 2001).  Future 
longitudinal studies could also speak to developmental differences.  Additionally, 
longitudinal studies will enable researchers to assess the effect of functional self-efficacy 
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on physical and psychological functioning as well as the direction of the causal relation 
between pain and self-efficacy.       
 
Initial Coping 
Keefe et al. (2004) suggest that future research should examine the relations 
between self-efficacy and both behavioral and cognitive coping strategies as self-efficacy 
may influence how one copes with pain.  Self-efficacy to cope with pain may be a 
common factor linking the various psychological influences on the experience of pain 
(O'Leary, 1985).  Self-efficacy is a significant predictor of whether people would use a 
particular coping strategy even after controlling for pain severity and outcome (Jensen, 
Turner, & Romano, 1991).  Thus, people’s confidence that they can carry out a behavior, 
not just that they think the behavior will produce good outcomes, is an important factor in 
predicting their use of coping strategies.   
Coping in child populations has been found to vary by age and stage of 
development.  Older children often use a greater number of coping strategies and may use 
strategies, such as avoidance, which require more cognitive abilities (Reid, Dubrow, & 
Carey, 1995).  It has been suggested that children at different developmental stages may 
involve people differently in their coping process because they look at problems 
relationally in different ways (Berg, Meegan, & Deviney, 1998).  Thus, it is possible that 
the relation between coping and self-efficacy changes across development.  In a study 
examining how general coping changes across adult development, it was found that age 
did not show a direct relation to coping, but that active coping was predicted by self-
efficacy while passive coping was not (Trouillet, Gana, Lourel, & Fort, 2009).  
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Additionally, researchers have shown that those patients in alcohol treatment who show 
increases in coping also report higher levels of alcohol related self-efficacy at follow-up 
(McKellar, et al., 2008).      
 
Initial Disability   
 The chronic pain literature shows that higher pain-related self-efficacy is 
associated with better physical and psychological functioning (e.g. Arnstein, 2000; Ayre 
& Tyson, 2001; Buckelew, et al., 1995; Denison, et al., 2004; Estlander, et al., 1994; 
Kaivanto, et al., 1995).  No studies have examined the longitudinal relation of pain-
related self-efficacy to later disability.   
 
Current Study  
The current study, which is part of a larger study, investigated how pain-related 
self-efficacy changes over the course of development, among individuals evaluated for 
chronic abdominal pain as children and adolescents.  This study also investigated what 
factors present at the initial medical evaluation for abdominal pain discriminated different 
patterns of change in pain-related self-efficacy.  In addition, the current study examined 
at what time change in pain-related self-efficacy levels is most influential in predicting 
outcomes.  Because this study was the first known study to examine the developmental 
changes in pain-related self-efficacy using longitudinal data analyses, analysis of 
hypothesized effects were accompanied by exploratory analyses. 
In this study, pain self-efficacy was assessed with the Problem-Focused Coping 
Potential (PFCP) scale on the Pain Beliefs Questionnaire (PBQ) as PFCP assesses beliefs 
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about one’s ability to cope in a manner that alleviates the problem of pain.  Functional 
self-efficacy was assessed with the Emotion-Focused Coping-Potential (EFCP) scale as 
EFCP assesses belief in one’s ability to handle having pain, and to carry on in spite of 
pain.  While these scales’ items are not as specific as many scales of pain-related self-
efficacy, they are a reasonable proxy.  The PBQ and its subscales are detailed below in 
the measures section.    
The study was longitudinal in design with four assessment points.  Each 
individual completed self-report measures at baseline (Time-one) in the clinic.  
Depending on the cohort and retention, participants then variously also participated in the 
2-week (Time-two) follow-up over the phone, the 6-month (Time-three) follow-up over 
the phone, and/or the long-term (Time-four) 5-15 year follow-up conducted in parts over 
the phone, in person, and via online questionnaires.  The details of the study design and 
who participated at specific time points are detailed below in the methods section.       
 
Research Questions and Hypotheses 
As there is no literature on the development of pain-related self-efficacy, 
exploratory analyses examined how pain self-efficacy and functional self-efficacy change 
over the course of development, both in terms of age and passage of time since the initial 
evaluation.  Specifically, the course of change describing early, mid-range, and late 
changes was modeled.  The following Hypotheses were tested.   
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Hypothesis 1:  Change in self-efficacy   
Given prior literature (Mulvaney, et al., 2006) showing larger changes in 
psychological variables initially than in a long-term follow-up of children with CAP, it is 
hypothesized that the greatest change in pain-related self-efficacy will occur early, 
between the initial clinic visit and the two-week follow-up.       
 
Hypothesis 2:  Gender 
It is hypothesized that females will begin with lower initial pain-related self-
efficacy levels and will demonstrate more increase over time given the literature in non-
pain domains that demonstrates this pattern, particularly in adolescents transitioning to 
adulthood in academic self-efficacy domains.    
 
Hypothesis 3:  Impact of age at initial visit 
Self-reported pain-related self-efficacy for patients who were older at the time of 
initial visit will be more strongly related with long-term outcomes than will pain-related 
self-efficacy for younger patients.  This hypothesis is based on the general self-efficacy 
literature that indicates self-efficacy of older children is more predictive of behavior than 
is self-reported self-efficacy of younger children.     
 
Hypothesis 4:  Relation of age to levels of self-efficacy   
Age at initial visit will not be related to differing levels of pain-related self-
efficacy given the current literature showing limited relations between pain-related self-
efficacy and age and the child literature demonstrating no relation between age and pain-
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related self-efficacy (Bursch, et al., 2006).  However, these patterns will be explored and 
detailed if there are differentiations.           
 
Hypothesis 5: Coping related to changes in pain-related self-efficacy  
As Bandura (1977a) theorizes experiences and accomplishments influence the 
development of self-efficacy, it is hypothesized initial coping will be related to changes 
in functional self-efficacy such that lower levels of Passive coping will predict increases 
in functional self-efficacy as people with lower passive coping are more engaged and 
more likely to have experiences of successful functioning.  To a lesser extent, higher 
levels of initial Accommodative coping will also relate to increases in functional self-
efficacy as Accommodative coping has aspects of acceptance and accommodation that 
relate to increased functioning.   
Exploratory analysis will examine whether initial levels of Active coping relate to 
changes in self-efficacy.  Active coping is often not strongly related to outcomes, so this 
question is exploratory in nature (Smith, Wallston, & Dwyer, 2003; L. S. Walker, Smith, 
Garber, & Claar, 2005). 
As pain self-efficacy is associated with ameliorating pain rather than coping with 
it, no hypotheses are made regarding the relation of initial coping and changes in pain 
self-efficacy; however, these relations will be explored if they exist.           
 
Hypothesis 6:  Disability at initial visit 
 The literature suggests that disability and pain–related self-efficacy are 
consistently related; however, little is known about the direction of causality.  It is 
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hypothesized that those with higher levels of disability at Time-one will show decreases 
in both pain self-efficacy and functional self-efficacy because they are experiencing a 
lack of success at functioning which would lower their self-efficacy.   
 Further research questions are aimed at understanding the importance of changes 
in pain-related self-efficacy in predicting outcomes.  No studies were found that examine 
how changes in pain-related self-efficacy relate to outcomes, so the hypotheses are 
primarily exploratory in nature.   
 
Hypothesis 7:  Change in pain-related self-efficacy predicting long-term outcomes.   
 The largest change in pain-related self-efficacy is hypothesized to occur early on; 
however, it is predicted that later change will have a greater impact on long-term 
outcomes because of its proximity in time to the outcomes.     
Analyses will examine the relation of change in pain-related self-efficacy to a 
variety of outcome variables at the long-term follow-up.  These variables will include 
physical functioning, severity of gastrointestinal symptoms, and mental health outcomes 
including symptoms of anxiety and depression utilizing measures described below.  
Given previous literature (Lackner, et al., 1996), it is predicted that functional self-
efficacy will be more predictive of long-term physical functioning than will pain self-
efficacy.        
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CHAPTER II 
 
METHODS 
 
Participants 
Power analyses were conducted to determine the number of participants needed to 
ensure adequate statistical power.  The traditional conventions of d=.2, .5, and .8 for 
small, medium, and large effect sizes (Cohen, 1992) were used.  The Diggle model 
(Diggle, Liang, & Zeger, 1994) for two equal groups was used.  These longitudinal power 
analyses were conducted on a hypothetical outcome with a mean of 50 and a standard 
deviation of 10 for ease in interpretation.  The power analyses were designed to 
determine how small a change could occur over time and be detected using traditional 
standards (alpha=5%).   
The power analyses assumed 4 waves conducted at an initial time point, two-
weeks, six-months, and 10.06 (the mean at the time of the power analysis) years after the 
initial visit.  Average cross-wave correlations for PFCP (r=0.44) and EFCP (r=0.42) were 
computed for the current sample and used in the power analyses to add validity to the 
estimates.  The sample at the time of the power analysis was weighted for the number of 
time points they contributed (4 time points=1, 3 time points=0.75, and 2 time points=0.5) 
in order to calculate the effective sample size that was be used in multilevel method 
analyses.  Those with only one time point were not included as they can be used only to 
estimate the intercept, but not the slope.  The weighted calculations resulted in an 
effective sample size of 246.75 and 247.25 people for PFCP and EFCP respectively.  
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According to the Diggle model, a small to moderate effect (d=0.28) in change in the end 
point of EFCP or PFCP could be detected by the power analysis sample size.  Thus, the 
sample size had adequate to excellent power to detect the hypothesized effects. 
 
Time-one Participants (N=863) 
Participants comprised three separate cohorts of consecutive new patients to the 
Pediatric Gastroenterology clinic at Vanderbilt University Medical Center.  Patients were 
referred to this tertiary care clinic for evaluation of abdominal pain after an evaluation by 
a primary care provider did not reveal any evidence of organic disease.  The three 
different cohorts initially participated at the clinic over the span of 15-years (1993-1995, 
1996-1999, and 2001-2007).  The same criteria and procedure were used across cohorts 
with some variation in the instruments collected across the years.  Eligibility criteria 
included:  1) a report of at least three abdominal pain episodes occurring over the course 
of three months in duration or longer severe enough to interrupt activities and 2) no 
evidence of organic disease, known chronic health condition, physical disability, or 
mental retardation.  At the time of the initial data collection, participants ranged in age 
from 8 to 18 years old. 
The first cohort, GICOPE, was collected from 1993-1995 and included 155 
participants in the Time-one data collection.  The majority of participants were females 
and the age ranged from 8-18 years of age.  Of those completing the Time-four follow-up 
assessment (N=79), the time since the clinic visit ranged from 12.83 to 16.167 years 
(M=14.17, SD=0.69), the age at follow-up ranged from 22 to 32 (M=25.91, SD=2.618), 
96.3% were Caucasian, and 47 (58.0%) were female.    
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The second cohort, Diary, was collected from 1996-1999.  Two hundred twenty-
nine families were initially contacted, 57 (25%) failed to meet eligibility criteria and 18 
(8%) families declined participation.  This resulted in a final sample of 154 participants, 
150 of these completed the Pain Beliefs Questionnaire (PBQ).  The participants ranged in 
age from 8-15.  Of those completing the Time-four follow-up assessment (N=50), the 
time since the clinic visit ranged from 9.58 to 13.08 years (M=11.145, SD=0.95), the age 
at follow-up ranged from 18-26 (M=21.82, SD=2.24), 91.3% were Caucasian, and 28 
(59.6%) were female.   
The third cohort, Clinic, was collected from 2001-2007.  This sample was 
comprised of a final sample of 558 participants.  The participants ranged in age from 8-
17.  Of those completing the Time-four follow-up assessment (N=129), the average time 
since the clinic visit equaled 6.10 years (SD=0.79), the age at follow-up ranged from 12-
28 (M=18.02, SD=2.89), 90.0% were Caucasian, and 70 (57.9%) were female.    
 
Time-two Participants (N=300).   
A portion of the participants from the GICOPE and the Diary cohorts participated 
in a two-week follow-up study conducted over the phone.  One hundred fifty-three 
participants who previously participated in the GICOPE study participated in this Time-
two data collection.  One hundred forty-seven participants who previously participated in 
the Diary study participated in this Time-two data collection.  The 300 participants 
ranged in age from 8-18 years (M=11.13, SD=2.35) and were predominately female 
(56.9%).   
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Time-three Participants (N=121) 
A portion of the participants from the GICOPE cohort participated in a six-month 
follow-up study conducted over the phone.  Participants ranged in age from 8-18 years 
(M=11.87, SD=2.59) and were predominately female (56.9%).  Additionally, all of the 
participants who completed the six-month follow-up also completed the two-week 
follow-up. 
 
Time-four Participants (N=254). 
Two hundred fifty-four participants, comprised from a mixture of all three 
cohorts, participated in the current study that involved a longitudinal follow-up.  
Participants were assessed five years or more following their initial participation, though 
three participants completed the Time-four assessment less than five years post the initial 
assessment.  Other eligibility criteria include having shifted from one developmental 
cohort (child=8-12, adolescent=12-18, adult=18+) to another developmental cohort.  Of 
the 254 participants, Time-one data are available for 250, Time-two data are available for 
122, and Time-three data are available for 62 participants.  Participants in this sample 
represent the following cohorts:  GICOPE N=78 (30.70%), Diary N=50 (19.69%), Clinic 
N=126 (49.61%).  Participants ranged in age from 12-32 (M=21.21, SD=4.37) and were 
predominately female (N=150, 59.5%).  The time since each participant completed the 
Time-one initial assessment ranged greatly, 2.83-16.167 years (Mean=9.56, SD=3.70).   
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Table 1.  Sample sizes who completed the PBQ at various time points 
Time 1 (clinic visit) Total DOPCAP 
GICOPE (1993-1995) 155 76 
Diary Study (1996-1999) 150 50 
Clinic (2001-2007) 558 124 
Time 1 TOTAL 863 250 
Time 2 (2 week follow-up) Total DOPCAP 
GICOPE (1993-1995) 153 74 
Diary Study (1996-1999) 147 48 
Clinic (2001-2007) 0 0 
Time 2 TOTAL 300 122 
Time 3 (6 month follow-up) Total DOPCAP 
GICOPE (1993-1995) 121 62 
Diary Study (1996-1999) 0 0 
Clinic (2001-2007) 0 0 
Time 3 TOTAL 121 62 
Time 4 (>=5 year follow-
up) 
Total DOPCAP 
GICOPE (1993-1995) 79 78 
Diary Study (1996-1999) 50 50 
Clinic (2001-2007) 129 126 
Time 4 TOTAL 258 254 
GICOPE=1st wave of participants, Diary=2nd wave of participants, Clinic=3rd wave of participants 
DOPCAP refers to the current study of Developmental Outcomes of Pediatric Chronic 
Abdominal Pain and is the long-term follow-up and Time-four assessment.   
Measures  
 
Self-reported pain-related self-efficacy.   
Pain Beliefs Questionnaire.  Participants completed the Pain Beliefs 
Questionnaire (PBQ; van Slyke, 2001; L. S. Walker, et al., 2005) at all four time points.  
The PBQ follows the framework set forth by Lazarus and Folkman (1984).  Conceptually 
derived subscales were gathered from the 32 items comprising the PBQ, including 
primary and secondary appraisals.  The PBQ contains two subscales assessing secondary 
appraisals:  one’s belief in her efficacy to cope in a problem-focused manner and alleviate 
pain (Problem Focused Coping Potential, PFCP); and one’s belief in her efficacy to cope 
in an emotionally-focused manner and cope in the presence of unremitting pain (Emotion 
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Focused Coping Potential, EFCP).  In the current study, PFCP is used as an indicator of 
pain self-efficacy and EFCP is used as an indicator of functional self-efficacy.  Each 
subscale is composed of six Likert scaled items anchored at “not at all true” (0) and “very 
true” (4) on a five point scale.  Items were reverse coded as appropriate.  The PFCP and 
EFCP subscales were calculated by summing the items to arrive at a total score.  High 
scores on the PFCP and EFCP subscales indicate higher self-efficacy.   
 The PBQ has been used in several studies examining pain-related self-efficacy 
(van Slyke, 2001; L. S. Walker, et al., 2005).  It has been used in studies involving 
children and adults.  In past research, the subscales have shown internal consistency and 
have significantly predicted health outcomes.  We have used the PBQ with both pediatric 
and adult samples.  Through the course of ongoing research investigating the PBQ’s 
factor structure using split-halves analyses, a refined version of the PBQ was utilized in 
this study.  This version of the PBQ eliminated item 11 from the PFCP subscale and item 
9 from the EFCP subscale as the internal consistency was improved when these items 
were excluded.  Alpha reliabilities in the two split halves for PFCP when item 11 was 
eliminated were good (0.82 and 0.77) as were alpha reliabilities for EFCP when item 9 
was eliminated (0.82 and 0.77).  Analyses affirmed the continued use of the dichotomy 
between the PFCP and EFCP subscales was warranted.  The PBQ appears in the 
appendix.    
 
Self-reported coping.   
Pain Response Inventory.  Participants completed the Pain Response Inventory (PRI; 
L. S. Walker, Smith, Garber, & Van Slyke, 1997) at both the initial assessment and the Time-
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four follow-up assessment.  The PRI is a 60-item questionnaire that assesses cognitive and 
behavioral responses to chronic or recurrent pain.  Items are assessed using a five point Likert 
scale.  The PRI generates broad scales for Active, Passive, and Accommodative coping as well 
as 13 subscales.  Active coping is comprised of seven subscales including problem-solving, 
seeking instrumental support, seeking emotional support, using distraction, rest, 
massage/guard, and condition-specific strategies.  Passive coping is comprised of three 
subscales including behavioral disengagement, self-isolation, and catastrophizing.  Finally, 
Accommodative coping is comprised of four subscales including acceptance, self-
encouragement, minimizing pain, and ignoring pain.  Test-retest reliability and construct and 
predictive validity have been documented in CAP patients.  The PRI appears in the appendix. 
 
Self-reported pain.   
Abdominal Pain Index.  Participants completed the Abdominal Pain Index (API; 
L. S. Walker, et al., 1997) at all four time points.  The API assesses the frequency, 
duration and intensity of abdominal pain episodes experienced in the previous two weeks.  
A total severity score is calculated by standardizing and summing each of these ratings.  
Past alpha reliabilities are reported as .80-.93.  The API was used to control for pain 
levels at various assessment times as well as an outcome measuring pain levels at follow-
up.  A single API item was also used to assess pain intensity over the prior two weeks.  
The API appears in the appendix.  
The Rome III Modular Questionnaire.  Participants completed a 24-item version 
of the Questionnaire on Pediatric Gastrointestinal Symptoms-Rome III Version (QPGS-
RIII) (Drossman, 2006) at the Time-four follow-up assessment.  The QPGS-RIII is an 
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adaptation of earlier versions and includes new items in order to assess symptom criteria 
for the current Rome III.  It assesses diagnostic symptom criteria for functional 
gastrointestinal disorders (FGIDs).  It can be scored for presence/absence of various 
FGIDs (e.g., IBS, functional dyspepsia).  The QPGS-RIII was used to assess the presence 
of CAP at Time-four follow-up.  The QPGS-RIII appears in the appendix.      
 
Self-reported functioning.   
The Functional Disability Inventory.  Participants completed the Functional 
Disability Inventory (FDI; Claar & Walker, 2006; Claar, Walker, & Smith, 1999; L. S. 
Walker & Greene, 1991) at three time points (baseline, two-week, and follow-up); 
however, those in the first cohort—GICOPE—only completed the FDI at the long-term 
follow-up.  The FDI is a self-report measure that assesses the impact of physical health on 
functioning where higher values indicate greater disability.  In CAP patients, coefficient 
alpha is .89 and three-month test-retest reliability is 0.60.  The FDI appears in the 
appendix.   
The Short Form Health Survey.  Each participant completed the 36 item Short 
Form Health Survey (SF-36; Ware & Sherbourne, 1992)  at the Time-four assessment.  
The SF-36 assesses eight domains of health perception:  1) physical functioning, 2) social 
functioning, 3) role limitations due to physical health, 4) bodily pain, 5) general mental 
health, 6) role limitations due to physical health, 7) energy and fatigue, and 8) general 
health perceptions.  For this study, the total score was use of an index of overall 
functioning.  Test-retest reliability and internal consistency for the SF-36 was reported to 
be good (e.g., Brazier et al., 1992).  The SF-36 appears in the appendix. 
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Depressive and anxiety symptoms.   
Center for Epidemiological Studies-Depression Scale.  Participants completed the 
Center for Epidemiological Studies-Depression Scale (CES-D; Radloff, 1977) scale at the 
Time-four follow-up assessment.  The CES-D is a self-report measure of the frequency of 20 
depressive symptoms over the past week.  The CES-D has previously shown to have good 
psychometric characteristics (Roberts et al., 1990) and has been used in previous longitudinal 
studies of chronic abdominal pain (Walker et al., 1998).  The CES-D appears in the appendix.     
Children’s Depression Inventory.  The Children’s Depression Inventory (CDI; Kovacs, 
1981 ; Kovacs & Beck, 1977) was administered at the baseline clinic visit.  The CDI is a self-
report measure with 27 items assessing children’s depressive symptoms.  Each symptom is 
rated on a 3-point scale.  The items are summed to calculate a total score.   
Spielberger State Trait Anxiety Index.  Participants completed trait subscale of the 
Spielberger State Trait Anxiety Index (STAI; Spielberger, 1983) at the Time-four follow-
up assessment.  The STAI trait subscale measures self-reported general or long standing 
anxiety.  The STAI trait subscale contains 20 items, each with a four point Likert scale 
ranging from “Almost Never” (1) to “Almost Always” (4).  The STAI is used an outcome 
measure of general anxiety at the time of follow-up.  The STAI appears in the appendix.   
 
Self-reported somatization. 
Child Somatization Inventory.  Participants completed the Child Somatization 
Inventory (CSI; Garber, Walker, & Zeman, 1991; L. S. Walker, Garber, & Greene, 1991) 
at all four time points including the Time-four follow-up assessment.  While the title 
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includes the word “child” the measure does not ask child specific items and was thus 
used with the adult participants as well as the child participants.  The CSI assesses 
perceived severity of 35 nonspecific somatic symptoms (e.g., headaches, dizziness, 
fatigue).  A recent revision (L. S. Walker, Beck, Garber, & Lambert, 2009) has refined 
this to 24 items and has demonstrated that the CSI is psychometrically solid.  The CSI 
appears in the appendix.  
 
Demographics.  
 Time variant and time invariant demographics were assessed at each time point.  
Age was asked explicitly and the participant’s date of birth was recorded at each time 
point as well, allowing specific age calculation to the day.  At Time-one through Time-
three, and for adolescent participants at Time-four, parents completed the demographics 
information in reference to their children.  Gender and race were assessed at each time 
point.  The time since each prior point of assessment was calculated to the day.      
 
Procedure 
 All data were collected via questionnaires.  Time-one data were collected via 
interviews where trained research assistants read choices and recorded participants’ 
responses.  The interviews were conducted in the gastroenterology clinic at Vanderbilt 
University prior to the participants’ initial clinic visit with the gastroenterologist.  Time-
one data were collected between the years of 1993 and 2007.  Research assistants then 
called participants in both wave one (GICOPE) and wave two (DIARY) two-weeks 
following the initial clinic visit.  At this follow-up phone call, Time-two data were 
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collected via interviews conducted over the phone.  Time-three data were collected for 
wave one (GICOPE) six-months following the initial clinic visit.  Again, research 
assistants called the participants who completed the questionnaires over the phone.   
Time-four data (DOPCAP, Developmental Outcomes of Pediatric Chronic 
Abdominal Pain) were collected for all three waves via a combination of phone interview 
and online questionnaire completion via Survey Monkey (an online mechanism for 
completing self-report questionnaires).  The following measures were completed over the 
phone:  Demographics, SF-36, CSI, FDI, PPQ, API, and the QPGS-RIII.  The following 
measures were completed via Survey Monkey at the completion of the study:  STAI, 
CES-D, PBQ, and the PRI.  As changes in the PBQ is the focus of this study, only 
participants who completed the Survey Monkey portion of the study were included in 
these analyses.  Additionally, though there was a three-month follow-up for wave one 
(GICOPE) and wave two (Diary), this follow-up did not include the PBQ and thus was 
not included in this study.      
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CHAPTER III 
 
RESULTS 
 
Data Cleaning 
 In order to use multi-level modeling it was necessary to configure the data set 
such that it is in person-period format.  This required that each individual have a row of 
data for each time point in which the individual participated (Singer & Willett, 2003).  
Typically, if a participant participated in Time-one and Time-four they would have two 
rows of data, thus eliminating the need for missing variables for people who did not 
complete all time points.  Each variable, for instance EFCP, had only one column and the 
various time points were captured in the appropriate row for each individual.  This 
transformation to a person-period data set can be performed by standard statistical 
packages.  However, given the unique nature of these data, a decision was made to use 
splines5
 Values of splines between baseline and two-weeks, two-weeks and six-months, 
and six-months and the long-term-follow-up were calculated for each participant for each 
spline regardless of participation in time point.  The average time between the time points 
was used for participants who did not participate in a specific time point.  The prior 
elapsed time was subtracted from the subsequent time points; thus, each spline had a 
value representing only the time in between the two specified time points.  This 
 rather than all four time points in one model.  Thus, four rows were retained for 
each participant.       
                                               
5 Splines are joined linear segments of longitudinal data that allow one to examine curved data using linear 
models as they result in “piecewise linear patterns” (Fitzmaurice, Laird, & Ware, 2004, p. 147).    
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prevented falsely long splines for those subjects who did not participate in the middle 
time points.     
 A standard time metric was utilized in order to properly log when each data wave 
was collected for each individual since there is some variability, particularly at the Time-
four wave.  Time was arranged such that the initial clinic visit (Time-one) was coded as 
zero (the intercept) and each time point coded as the specific number of days since the 
initial clinic visit for that particular individual.  When an individual did not participate in 
a particular time point, time was coded as the average days in time for those individuals 
who did participate in that time point.  This transformation of Time-one to a zero or 
intercept metric enabled clear longitudinal modeling.  In the results, information is 
sometimes presented as weeks or years rather than days for clarity as the number of days 
when there are several years becomes excessive, but both weeks and years are based on 
the time in days where there are 365 days in a year, 30 days in a month, and 7 days in a 
week.       
 Subjects who met criteria for an organic diagnosis responsible for their abdominal 
pain at the time of the initial clinic visit were excluded from this current study.  This 
included two individuals from the GICOPE study because of a diagnosis of Crohn’s 
disease.  Three individuals were excluded from the Diary study, two for ulcerations and 
one for Crohn’s disease.  Four individuals were excluded from the clinic, one because of 
Celiac disease and the four due to Crohn’s disease.   
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Primary Data Analyses  
  Multi-level modeling methods were used to test hypotheses one through five as 
these hypotheses focused on determining the change in pain-related self-efficacy over the 
course of development and thus needed to model the slope and intercept of this change 
(Singer & Willett, 2003).  Multi-level modeling methods were particularly useful for this 
study design because they allow for flexibility in dealing with missing data caused by 
differences in which time points were collected, in which studies, and who participated in 
each time point.  Variability in the number of waves collected is called “unbalanced data” 
and participants’ statistical contributions to the model are weighted according to the 
number of waves collected.  Additionally multi-level modeling is flexible in terms of 
using “time unstructured” data meaning that the waves do not have to occur at the same 
time for each participant (Singer & Willett, 2003).  Having data collection weighted 
toward the earlier time points is acceptable and is preferred when it is thought that the 
majority of change occurs early on, as is hypothesized in this study (Singer & Willett, 
2003).   
 Models were constructed to fit the data.  Initially, a general model was 
constructed, including information obtained from the observed intercept, Time-one self-
efficacy ratings, and observed slope.  The pattern of change was divided into three 
splines, an early spline (Time-one to Time-two) a middle spline (Time-two to Time-
three) and a late spline (Time-three to Time-four).  Even though Hierarchical Linear 
Modeling (HLM) is resistant to variability, the great variability of times and long time 
between the 3rd and 4th time point made a three spline approach desirable in order to 
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avoid predicted curves across years based on limited information.  Splines allowed for 
evaluation of hypothesis one and whether the greatest change occurs early on.  
Additionally, by splitting the model into three splines, the study controlled for any effect 
of the initial medical appointment, which occurred between Time-one and Time-two, on 
self-efficacy levels by not including Time-one data points with the other splines.  The 
model incorporated three parameter estimates:  intercept (Time-one), slope or rate of 
change in pain-related self-efficacy across the applicable time points, and an error 
component.     
 Based on the models, two variables representing an individual’s rate of early and 
late change in self-efficacy, or slope, were calculated and captured in a data set.  Initially, 
these slope variables were then used in order to assess hypothesis seven, at what point 
since Time-one is change in self-efficacy most predictive of long-term outcomes.  
However, it was later determined that using actual slope scores, calculated by subtracting 
the first time point of interest from the second time point of interest and dividing by the 
amount of time in between these assessments, was a more accurate and desirable 
approach.  Even though using predicted slopes from HLM models would allow all 
participants to be included and provide a larger N, they are not preferred as the largest 
interval, Time-three to Time-four, was based on only one cohort and thus a fairly small 
proportion of the participants.  Thus, even though using actual slope scores reduces the 
sample size, the increase in accuracy is desirable and was considered to be more 
important than the greater sample size.  An example slope calculation is as follows:  for 
the slope between the six-month follow-up and the long-term follow-up, Time-three 
values were subtracted from Time-four values and then this value was divided by the 
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time between the six-month follow-up and the long-term follow-up.  However, given the 
large variability in Time-four follow-up, a dummy code of the average length in time 
between the six-month follow-up and the long-term follow-up was used in calculating the 
slope.  This is because there is not hypothesized to be a continuous linear change 
occurring several years out from the initial evaluation and using actual time would create 
very disparate divisors in the calculation of the slope.      
Linear regression was then used to determine which slope was more predictive of 
outcomes.  The predictor variables and the step on which they were entered was as 
follows: (1) baseline measures of the outcome variable when available, FDI, CSI, API, 
and ROME III (the CDI, an alternative form assessing depression symptoms that was 
assessed at Time-one was entered in this initial step for rather than the CES-D) (2) the 
slope variables for early, middle, and late or Time-one to Time-four change in pain-
related self-efficacy alone.  The overall slope was not included in the same analyses as 
interval slopes.  This sequence allowed initial levels of the outcome variable to be 
controlled and to determine whether specific slopes or the overall slope accounts for 
greater variance.  The same model was applied to each outcome variable.     
The results of these analyses are below:    
 
Hypothesis 1:  Change in self-efficacy   
The first hypothesis predicted the largest change in pain-related self-efficacy 
would occur early on.  Hierarchical linear modeling demonstrated that the change in 
PFCP from the initial clinic visit to the two-week follow-up and the change in PFCP from 
the two-week follow-up to the six-month follow-up were both significant increases 
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(Table 2, Figure 1).  However, the change in PFCP from the six-month follow-up to the 
long-term follow-up was not significant (Table 2).   
 
 
Figure 1: Predicted change in PFCP over time 
  
The X-axis represents years.  The break in the X-axis is between the 6-month and long-term follow-up to 
indicate a large passage of time.   
 
The change in EFCP from the initial clinic visit to the two-week follow-up, from 
the two-week follow-up to the six-month follow-up, and the change in EFCP from six-
month to long-term follow-up were all significant.  These significant findings indicated 
significant increases in emotion-focused coping potential across all time points (Table 2, 
Figure 2). 
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Figure 2: Predicted change in EFCP over time 
  
The X-axis represents years.  The break in the X-axis is between the 6-month and long-term 
follow-up to indicate a large passage of time.   
 
 
Outcome 
Variable 
Table 2:  Change in PFCP and EFCP over time using HLM 
% of  
variance 
due to 
individual 
differences 
(ICC) 
Intercept 
level  
Estimate of 
point 
change per 
week  from 
T1-T2  
Estimate of 
point 
change per 
week from 
T2-T3 
Estimate 
of point 
change per 
year from 
T3-T4 
Degrees 
of 
Freedom  
PFCP 45.35***  2.07*** 0.15***  
t=5.70*** 
0.01*** 
t=4.57*** 
-0.003 
t=-0.39 
672 
EFCP 56.08*** 2.53*** 0.11*** 
t=5.12*** 
0.02*** 
t=6.87*** 
0.04*** 
t=5.69*** 
672 
*p<.05       **p<.01       *** p<.001           
 
 
As predicted in hypothesis one, for both EFCP and PFCP, the largest increase did 
indeed occur early on—between the initial clinic visit and the two-week follow-up.  The 
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large significant Intraclass Correlations (ICC) also indicated that a significant proportion 
of the variability in the models was due to individual differences6
 
.   
Hypothesis 2:  Gender 
The second hypothesis predicted that females would start with lower self-efficacy 
ratings and then show a larger increase over time.  T-tests of means indicated that males 
had significantly higher levels of both PFCP and EFCP than females at the initial visit 
and two-week follow-up (Table 3, Figure 3, and Figure 4). 
 
 
Table 3:  T-tests of average PFCP and EFCP levels by gender. 
PFCP 
Means 
T-test (df) P-values EFCP 
Means 
T-test (df) P-values 
Baseline      M: 
                    F: 
2.26  
1.93 
-4.69 (860) <0.001 2.70 
2.41 
-4.31 (860) <0.001 
Two-week   M: 
                    F: 
2.65 
2.25 
-3.82 (298) <0.001 2.98 
2.63 
-3.20 (298) 0.001 
Six-month   M: 
                    F: 
2.77 
2.79 
0.09 (119) 0.93 3.16 
3.24 
0.57  (119) 0.57 
Long-term   M: 
                    F: 
2.75 
2.58 
-1.57 (254) 0.12 3.60 
3.47 
-1.76 (254) 0.08 
 
 
 T-tests indicate that the difference in PFCP at initial visit was significant between 
males and females.  Additionally, t-tests demonstrate that PFCP continued to be higher 
for males at the two-week follow-up, but not at the other two time points (Table 2 and 
Figure 3).  Using hierarchical linear modeling, gender significantly differentiated initial 
                                               
6 The percent of variance due to individual differences refers to the Intraclass Correlation Coefficient (ICC) 
and represents the proportion of the total variance due to individual differences (Singer & Willett, 2003).  
Size of individual differences as decimals are classified as follows:  small=0.05, medium=0.10, large=0.15 
(Raudenbush & Xiaofeng, 2000).    
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PFCP levels such that females’ scores were estimated to be 0.33 points lower than males 
(t=-4.94, p<.0001, df=668).  However, the interactions of gender and time segment 
(initial to two-weeks, two-weeks to six-months, and six-months to long-term follow-up) 
indicated that the pattern of change in PFCP over time were not significantly different by 
gender for any of these time segments (t=-0.49, p=0.63, df=668; t=1.27, p=0.20, df=668; 
t=-0.26, p=0.79, df=668).  In this HLM model, the ICC  indicated that 44 percent of the 
variance was due to individual differences.         
 
 
Figure 3: Actual mean values of PFCP by gender 
 
The X-axis represents years.  The break in the X-axis is between the 6-month and long-term 
follow-up to indicate a large passage of time.   
 
T-tests indicated that the difference in EFCP at initial visit was significant 
between males and females.  Additionally, t-tests demonstrated that EFCP continued to 
be higher for males at the two-week follow-up, but not at the other two time points (Table 
3 and Figure 4).  Using hierarchical linear modeling, gender significantly differentiated 
initial EFCP levels such that females’ scores were estimated to be 0.29 points lower than 
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males at baseline (t= -4.67, p<.0001, df=668).  However, the interactions of gender and 
time segment (initial to two-weeks, two-weeks to six-months, and six-months to long-
term follow-up) indicated that the pattern of changes in EFCP over time were not 
significantly different by gender for any of these time segments (t=-0.59, p=0.56, df=668; 
t=1.29, p=0.20, df=668; t=-0.05, p=0.97, df=668).  In this HLM model, the ICC indicated 
that 55 percent of the variance was due to individual differences. 
 
 
Figure 4: Actual mean values of EFCP by gender       
 
The X-axis represents years.  The break in the X-axis is between the 6-month and long-term 
follow-up to indicate a large passage of time.   
 
As predicted in hypothesis two, there were significant differences in pain-related 
self-efficacy by gender.  Specifically, females started with significantly lower values of 
both PFCP and EFCP.  These differences then became insignificant, which may imply 
that relative to males’ increase in self-efficacy ratings, females had a greater increase 
over time though the rates of change were not significantly different.   
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Hypothesis 3:  Impact of age at initial visit 
Hypothesis three was that the self-efficacy ratings of patients who were older at 
baseline would be more predictive of outcomes than the scores of younger patients.  In 
order to test this hypothesis and to clarify interpretation of the results, initial age in days 
was adjusted such that the youngest individual’s age was set to zero.  An HLM approach 
showed that when PFCP and age were included in the model initial age was a significant 
predictor of centered values of somatization (CSI) and pain intensity.  These relations 
indicated higher symptom severity with older age.  However, age was not a significant 
predictor of functional disability (FDI).  The interaction of PFCP and age at initial visit 
did not significantly relate to any outcome measure.  This indicated that for each year 
increase in age there was no change in the relation between PFCP and outcome measures 
(Table 4).  Each of these outcome values was evaluated in separate models and the 
majority had large proportions of their variance due to individual or between subject 
differences.         
 
Outcome 
Variable 
Table 4:  Impact of initial age and PFCP on various outcome measures using HLM  
% of  
variance 
due to 
individual 
difference
s 
(ICC) 
Intercept 
level of 
outcome 
assuming 
where age 
and 
PFCP are 
zero 
Estimate 
of point 
change in 
outcome 
for each 
point 
increase 
of PFCP  
Estimate 
of point 
change in 
outcome 
for each 
year 
increase in 
Age at 
baseline 
Estimate 
of 
influence 
of 
interaction 
of PFCP 
and Age at 
T1 on 
outcome 
Degrees 
of 
Freedom  
FDI 54.14*** 8.94*** 
t= 15.37 
-3.21*** 
t= -6.66 
0.19 
t= 1.56 
-0.07 
t= -0.72 
304 
Pain Intensity 24.4*** 4.98*** 
t= 36.11 
-0.90*** 
t= -7.20 
0.08** 
t= 2.76 
0.04 
t= 1.61  
556 
CSI 50.00*** 0.52*** 
t= 21.97 
-0.13*** 
t= -6.89 
0.02*** 
t= 4.77 
-0.003 
t= -.072 
651 
*p<.05       **p<.01       *** p<.001            
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An HLM approach to hypothesis three regarding EFCP showed that initial age 
was a significant predictor of centered values of Functional Disability (FDI), pain 
intensity, and somatization (CSI).  The interaction of EFCP and age at initial visit did not 
significantly relate to any outcome measures (Table 5).     
 
Table 5:  Impact of initial age and PFCP on various outcome measures using HLM 
Outcome 
Variable 
% of  
variance 
due to 
individual 
difference
s 
(ICC) 
Intercept 
level of 
outcome 
assuming 
where age 
and 
EFCP are 
zero 
Estimate 
of point 
change 
in 
outcome 
for each 
point 
increase 
of EFCP  
Estimate of 
point 
change in 
outcome for 
each year 
increase in 
Age at 
baseline 
Estimate 
of 
influence 
of 
interaction 
of EFCP 
and Age at 
T1 on 
outcome 
Degrees 
of 
Freedom  
FDI 53.87***  8.42*** 
t= 15.25 
-4.90*** 
t= -10.66 
0.36** 
t= 3.04 
0.11 
t= 1.15 
304 
Pain Intensity 22.52*** 4.77*** 
t= 35.68 
-0.99*** 
t= -8.08 
0.12*** 
t= 4.36   
0.02 
t= 0.76 
556 
CSI 53.87*** 0.48*** 
t= 21.38 
-0.18*** 
t= -10.62 
0.03*** 
t= 6.62 
<0.001 
t= 0.00 
651 
*p<.05       **p<.01       *** p<.001           
 
Overall, the findings did not support hypothesis three.  Results indicated a lack of 
difference in pain-related self-efficacy’s predictive utility of long-term outcomes based 
on age at initial visit.   
 
Hypothesis 4:  Relation of age to levels of self-efficacy   
Hypothesis four examined the impact of age at baseline on pain-related self-
efficacy and predicted that initial age would not be related to differing levels of self-
efficacy.  In the simplest model when only initial age—calculated such that the minimum 
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age was zero—was included, for each year increase in initial age above the minimum age 
of 8, the PFCP score was 0.07 (t= -5.54, p<.001, df=671), with 8 year olds having an 
average PFCP score of 2.50 at baseline.  Across time points, for each year increase in 
age, PFCP decreased by 0.08 points (t=-5.94, p<0.001, df=667).  Across time points, for 
each year increase in age at initial visit, PFCP decreased by 0.08 points (t=-5.92, 
p<0.001, df=665).  Correlation analyses indicated that age at initial visit was negatively 
correlated with PFCP at baseline, two-week follow-up, and six-month follow-up but at 
not the long-term follow-up (Table 6). 
 
 
Table 6:  Correlations between Age at Baseline and PFCP across time points     
Time one 
PFCP  
Time two 
PFCP 
Time three 
PFCP 
Time four 
PFCP 
Age at Baseline r=-0.19 
p<.0001 
N=863 
r=-0.15 
p=0.01 
N=300 
r=-0.24 
p=0.01 
N=121 
r=-0.08 
p=0.21 
N=258 
   
In the simplest model when only initial age was included, age at initial visit was 
not significantly related to EFCP levels at baseline, with 8 year-olds having a score of 
2.78 at baseline.  Across time points, EFCP did not vary significantly by age (t=-0.41, 
coefficient=-0.01, p=0.68).  Across time points, EFCP did not vary significantly by age at 
initial visit (t= -0.90, coefficient -0.01, p=0.37).  Correlation analyses indicated that age 
at the clinic visit was not significantly correlated with EFCP at any time point (Table 7). 
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Table 7:  Correlations between Age at Baseline and EFCP across time points     
Time one 
EFCP  
Time two 
EFCP 
Time three 
EFCP 
Time four 
EFCP 
Age at 
Baseline 
r=-0.02 
p=0.47 
N=863 
r=-0.05 
p=0.40 
N=300 
r=-0.05 
p=0.61 
N=121 
r=-0.06 
p=0.32 
N=258 
 
None of the interactions between age and time segments for either PFCP or EFCP 
were significant, thus the changes in PFCP and EFCP between time points were not 
related to age.  None of the interactions between initial age and time segments for either 
PFCP or EFCP was significant thus the changes in PFCP and EFCP between time points 
were not related to age at initial visit.  Therefore, analyses confirm that age at initial visit 
did not differentiate patterns of change in self-efficacy.  However, younger age at initial 
visit related to higher PFCP at the baseline, two-week, and six-month assessments.     
 
Hypothesis 5: Coping related to changes in pain-related self-efficacy  
 The fifth hypothesis predicted that initial coping would be related to changes in 
pain-related self-efficacy with lower levels of initial Passive coping relating to increases 
in functional self-efficacy (EFCP) and higher levels of initial Accommodative coping 
predicting increased EFCP.  Regression analyses were used in order to isolate initial 
coping values as predictors.  Change in EFCP was assessed by controlling for initial 
EFCP levels and looking at later EFCP levels as the outcome.   
Regression analyses, controlling for initial levels of EFCP, were conducted to 
examine the relative contribution of Passive, Accommodative, and Active coping on 
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change in EFCP over various time increments.  Long-term EFCP was predicted by 
Passive coping such that lower initial Passive coping predicted higher long-term EFCP 
(Table 8) and the addition of various coping types accounted for an additional five 
percent of the variance beyond that accounted for by Time-one EFCP.  This was in the 
hypothesized direction.    
 
Predictor Variable 
Table 8:  Multiple Regression Analysis Examining the Impact of Types of 
Coping on Long-term EFCP.   
Β T R2 change 
Step 1:  Predictor Variables   0.06*** 
     Time 1 EFCP centered 0.24 3.93***  
Step 2:     0.05** 
     Time 1 EFCP 0.17 2.15*  
     Active Coping T1 -0.04 -0.60  
     Accommodative Coping T1 -0.12 -1.81  
     Passive Coping T1 -0.18 -2.31*  
*p<.05                                  **p<.01    
*** p<.001                           df=251    
 
  Lower initial Passive coping also predicted early change in EFCP as higher two-
week EFCP was significantly predicted by Time-one Passive coping when initial EFCP 
was controlled (Table 9).  No coping scales predicted the changes between two-weeks 
and six-months and six-months and the long-term follow-up.  This may be because of the 
small sample size in analyses involving the six-month follow-up as only the GICOPE 
cohort participated at this time point.  These findings partially support the hypothesis as 
lower initial Passive coping did relate to later higher EFCP, but Accommodative coping 
was not predictive.  This fits with the larger literature where Passive coping is a stronger 
predictor than Accommodative coping (e.g., Grant, Long, & Willms, 2003; Litt, Shafer, 
& Napolitano, 2004; L. S. Walker, et al., 2005; L. S. Walker, et al., 1997). 
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Predictor Variable 
Table 9:  Multiple Regression Analysis Examining the Impact of Types of 
Coping on two-week EFCP scores.   
Β T R2 change 
Step 1:  Predictor Variables   0.58*** 
     Time 1 EFCP centered 0.76 20.01***  
Step 2:     0.02** 
     Time 1 EFCP 0.63 11.81***  
     Active Coping T1 -0.02 -0.36  
     Accommodative Coping T1 0.06 1.34  
     Passive Coping T1 -0.17 -3.44**  
*p<.05                                  **p<.01    
*** p<.001                           df=297    
       
Regression analyses, controlling for initial values of PFCP, were conducted to 
examine the relative contribution of Passive, Active, and Accommodative coping on later 
PFCP scores, though no a priori hypothesis were made.   
Changes in PFCP were predicted by various types of coping.  No coping subscale 
predicted long-term PFCP scores when controlling for Time-one PFCP levels.  However, 
both initial Passive and Accommodative coping significantly predicted two-week follow-
up PFCP scores when Time-one PFCP was controlled (Table 10) such that lower initial 
Passive coping and higher initial Accommodative coping predicted higher two-week 
PFCP.  Initial Passive coping also predicted long-term follow-up scores in the opposite 
direction when the six-month scores were controlled such that higher initial Passive 
coping predicted a greater increase in PFCP from the six-month to long-term follow-up 
(Table 11).  Thus, initial Passive coping was predictive of later changes in PFCP even 
when there was a small sample size, but it did not account for a significant amount of 
variability beyond that predicted by Time-three PFCP.  
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Predictor Variable 
Table 10:  Multiple Regression Analysis Examining the Impact of Types of 
Coping on two-week PFCP scores.   
Β T R2 change 
Step 1:  Predictor Variables   0.53*** 
     Time 1 PFCP centered 0.73 18.19***  
Step 2:     0.03** 
     Time 1 PFCP 0.63 13.26***  
     Active Coping T1 0.04 1.03  
     Accommodative Coping T1 0.14 3.32**  
     Passive Coping T1 -0.11 -2.26*  
*p<.05                                  **p<.01    
*** p<.001                           df=297    
 
 
Predictor Variable 
Table 11:  Multiple Regression Analysis Examining the Impact of Types of 
Coping on Slope of Change in PFCP from Time 3 to Time 4.   
Β T R2 change 
Step 1:  Predictor Variables   0.21*** 
     Time 3 PFCP 0.46 4.01  
Step 2:     0.07 
     Time 3 PFCP 0.56 4.48  
     Active Coping T1 -0.21 -1.738  
     Accommodative Coping T1 0.07 0.65  
     Passive Coping T1 0.29 2.19*  
*p<.05                                  **p<.01    
*** p<.001                           df=61    
 
 
Analysis of the impact of coping on PFCP was exploratory, but the findings 
paralleled those for EFCP in that low Passive coping predicted increases in PFCP; 
however for PFCP this was only early changes and then in the opposite direction for late 
change.  Additionally higher initial Accommodative coping related to higher two-week 
PFCP which was not expected, but was in a direction that makes conceptual sense.   
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Hypothesis 6:  Disability at initial visit 
Hypothesis six was that those with higher levels of disability at baseline would 
show decreases in both PFCP and EFCP.  Given that GICOPE subjects did not complete 
the FDI at any of the time points prior to the long-term follow-up and the GICOPE cohort 
was the only cohort that participated in a six-month follow-up, HLM was not used to 
analyze this hypothesis.  Regression analysis using the FDI at Time-one and examining 
the change in PFCP and EFCP between baseline and the two-week follow-up and 
between baseline and the long-term follow-up were conducted.  This was done by 
controlling for Time-one PFCP or EFCP levels and including Time-one FDI levels as a 
predictor of the Time-two or long-term follow-up PFCP or EFCP scores.     
Results did not demonstrate any significant ability for baseline FDI scores to 
predict either two-week or long-term PFCP scores when controlling for baseline PFCP 
scores (Table 12 and Table 13).   
 
Predictor Variable 
Table 12:  Multiple Regression Analysis Examining the Impact of 
Functional Disability at baseline on Two-week Follow-up PFCP scores.   
Β T R2 change 
Step 1:  Predictor Variables   0.53*** 
     Time 1 PFCP centered 0.73 12.76***  
Step 2:     0.001 
     Time 1 PFCP centered 0.71 11.43***  
     FDI sum at Time 1 centered -0.04 -0.65  
*p<.05                                  **p<.01    
*** p<.001                           df=146    
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Predictor Variable 
Table 13:  Multiple Regression Analysis Examining the Impact of 
Functional Disability at baseline on Long-term Follow-up PFCP scores.   
Β T R2 change 
Step 1:  Predictor Variables   <0.001 
     Time 1 PFCP centered 0.02 0.23  
Step 2:     0.005 
     Time 1 PFCP centered -0.01 -0.06  
     FDI sum at Time 1 centered -0.07 -0.94  
*p<.05                                  **p<.01    
*** p<.001                           df=176    
 
 
Regression analyses did show a significant negative relation between baseline 
FDI scores and higher EFCP at the two-week follow-up such that greater baseline 
disability predicted lower EFCP after controlling for baseline levels (Table 14), though it 
explained only an additional two percent of the variance beyond that explained by Time-
one EFCP.  However, baseline FDI did not significantly predict long-term follow-up 
levels of EFCP when controlling for Time-one EFCP (Table 15).  
 
Predictor Variable 
Table 14:  Multiple Regression Analysis Examining the Impact of Functional 
Disability at baseline on Two-week Follow-up EFCP scores.   
Β T R2 change 
Step 1:  Predictor Variables   0.57*** 
    Time 1 EFCP centered 0.76 13.88***  
Step 2:     0.02* 
     Time 1 EFCP centered  0.70 11.99***  
     FDI sum at Time 1 centered -0.15 -2.58*  
*p<.05                                  **p<.01    
*** p<.001                           df=146    
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Predictor Variable 
Table 15:  Multiple Regression Analysis Examining the Impact of 
Functional Disability at baseline on Long-term Follow-up EFCP scores.   
Β T R2 change 
Step 1:  Predictor Variables   0.08*** 
    Time 1 EFCP centered 0.28 3.81***  
Step 2:     0.01 
     Time 1 EFCP centered  0.25 3.20**  
     FDI sum at Time 1 centered -0.08 -0.99  
*p<.05                                  **p<.01    
*** p<.001                           df=176    
 
 
Overall, there was only limited statistical support for hypothesis six, but much of 
it was not confirmed.  Baseline FDI was predictive of only early change in EFCP and was 
not predictive of any change in PFCP.   
 
Hypothesis 7:  Change in pain-related self-efficacy predicting long-term outcomes.   
Hypothesis seven asserted that the later changes in PFCP and EFCP would have 
the greatest impact on long-term outcomes.  Additionally, it hypothesized that EFCP 
would have more impact on physical functioning than would PFCP.  Actual calculated 
slope scores (e.g. [T4EFCP-T1EFCP]/[Time4-Time1] where Time1=zero as it is the 
initial clinic visit) were calculated rather than using predicted slope scores produced by 
HLM models.  This statistical approach was taken given that the predicted slopes were 
based on very long intervals between either the two-week or six-month follow-up and the 
long-term follow-up.  Thus, it is unclear that the pattern predicted would accurately 
capture what occurred in the interim.  Using actual slopes was a more conservative 
approach both because it uses actual values and because it necessarily uses a smaller 
sample size.   
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Slopes rather than absolute change scores were used in order to account for the 
variability in time between the initial clinic visit and the long-term follow-up.  However, 
given the large variability in Time-four follow-up, a dummy code consisting of the 
average length in time between the six-month follow-up and the long-term follow-up was 
used in calculating the slopes including the six-month interval.  Dummy coding was used 
because there was not hypothesized to be a continuous linear change occurring several 
years out from the baseline and using actual time would create very disparate divisors in 
the calculation of the slope.  Where applicable, various slope scores including slopes 
between Time-one and Time-two were included.  However, inclusion of slopes in 
regression analyses limited the sample size for any particular analysis to the number of 
subjects who had all of the time points included in the slopes. 
Regression analyses using the slope scores for either PFCP or EFCP were 
conducted, examining the relative influence of rate of change in pain-related self-efficacy 
on outcomes of interest.  Baseline measures of the outcome variable were included in the 
first block unless otherwise stated.   
Lower functional disability at follow-up, as measured by the FDI, was 
significantly predicted by increases in PFCP from Time-one to Time-four (β= -0.29, t=-
3.96, df=160, p<0.001) and by increases in EFCP from Time-one to Time-four (β= -0.28, 
t=-3.12, df=160, p<0.001) when they were entered independently.  When the slopes of 
both PFCP and EFCP from Time-one to Time-four were included in the regression 
model, only changes in PFCP (Table 16) remained significant.  Neither the PFCP nor 
EFCP slope from Time-one to Time-two were predictive of FDI at Time-four (β=0.14, 
t=-1.08, p=0.29, df=43; β= -0.20 t=-1.51, p=0.14, df=43).  As FDI scores were collected 
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only at baseline in the Diary and Clinic samples and only at two-week follow-up in the 
Diary sample, the sample size was reduced.  As GICOPE participants—and consequently 
the entire six-month follow-up—were excluded because they did not complete the FDI 
prior to the long-term follow-up, only early slopes and overall slopes were assessed.       
 
Predictor Variable 
Table 16:  Multiple Regression Analysis Examining the Impact of rate of 
change of Pain-Related Self-Efficacy on Functional Disability at Follow-up.   
Β T 
R2 
change 
Step 1:  Predictor Variables   0.11*** 
     FDI sum at Time 1 centered 0.33 4.36***  
Step 2:     0.10*** 
     FDI sum at Time 1 centered 0.39 5.34***  
     Slope of change in PFCP Time 1 to Time 4 -0.20 -2.37*  
     Slope of change in EFCP Time 1 to Time 4 -0.17 -1.96  
*p<.05                                  **p<.01    
*** p<.001                           df=160    
 
In a separate analysis, neither initial levels of PFCP or EFCP were predictive of 
long-term FDI (Table 17), indicating that it is the change, not the initial levels of pain-
related self-efficacy that predicted less functional disability.   
 
Predictor Variable 
Table 17:  Multiple Regression Analysis Examining the Impact initial levels 
of Pain-Related Self-Efficacy on Functional Disability at Follow-up.   
Β T 
R2 
change 
Step 1:  Predictor Variables   0.11*** 
     FDI sum at Time 1 centered 0.33 4.48***  
Step 2:     0.003 
     FDI sum at Time 1 centered 0.35 4.36***  
     Time 1 PFCP centered  0.05 0.61  
     Time 1 EFCP centered 0.03 0.03  
*p<.05                                  **p<.01    
*** p<.001                           df=164    
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Higher overall functioning, as measured by the SF-36, was significantly predicted 
by increases in PFCP from Time-one to Time-four (β= 0.20, t=3.07, p=.002, df=230) but 
not by increases in EFCP from Time-one to Time-four (β= 0.13, t=1.94, p=0.05, df=230).  
However, it was not clear when changes in pain-related self-efficacy are most predictive 
as none of the slopes between consecutive time points was significantly predictive when 
they were included in one model for EFCP and a separate model for PFCP (PFCP: T1-
T2 β= 0.02, t=0.15, p=0.88, df=59; T2-T3 β= 0.04, t=0.24, p=0.81, df=59; T3-T4 β= 
0.03, t=0.20, p=0.84, df=59; EFCP: T1-T2 β= 0.13, t=0.89, p=0.38, df=59 T2-T3 β= 
0.004, t=0.03, p=0.98, df=59; T3-T4 β= 0.13, t=0.96, p=0.34, df=59).  This is potentially 
due to decreased sample size.  When both PFCP and EFCP were included in the model, 
only rate of change in PFCP from Time-one to Time-four remained significant (Table 
18).  As the SF-36 was not included at baseline, no baseline measures were included in 
the model.   
 
Predictor Variable 
Table 18:  Multiple Regression Analysis Examining the Impact of rate of 
change of Pain-Related Self-Efficacy on SF-36 overall functioning at Follow-up.   
Β T R2 change 
Step 1:  Predictor Variables   0.04** 
     Slope of change in PFCP Time 1 to Time 4 0.18 2.41*  
     Slope of change in EFCP Time 1 to Time 4   0.04 0.53  
*p<0.05                   **p<0.01    
*** p<0.001              df=230    
 
 
In a separate analysis, neither initial levels of PFCP or EFCP were predictive of 
long-term SF-36 (Table 19), indicating that it is the change in PFCP, not the initial levels 
of pain-related self-efficacy that predict overall functioning.   
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Predictor Variable 
Table 19:  Multiple Regression Analysis Examining the Impact initial levels 
of Pain-Related Self-Efficacy on SF-36 overall functioning at Follow-up.   
Β T 
R2 
change 
Step 1:  Predictor Variables   0.01 
     Time 1 PFCP centered  0.05 0.72  
     Time 1 EFCP centered 0.02 0.30  
*p<.05                                  **p<.01    
*** p<.001                           df=236    
 
Symptoms of depression, as measured by the CES-D, were significantly predicted 
by rate of change in PFCP and EFCP between Time-one and Time-four indicating 
increases in pain-related self-efficacy related to lower symptoms of depression at follow-
up (Table 20 and Table 21).  However, it is not clear when changes in pain-related self-
efficacy were most predictive as none of the slopes between consecutive time points was 
significantly predictive when they were included in one model for EFCP and a separate 
model for PFCP (PFCP: T1-T2 β= -0.08, t= -0.66, p=0.51, df=60; T2-T3 β= 0.16, 
t=1.21, p=0.23, df=60; T3-T4 β= 0.11, t=0.88, p=0.38, df=60; EFCP: T1-T2 β= -0.03, t= 
-0.25, p=0.80, df=60 T2-T3 β= 0.11, t=0.88, p=0.39, df=60; T3-T4 β= -0.14, t= -1.05, 
p=0.30, df=60).  This is potentially due to decreased sample size.  When both PFCP and 
EFCP were included in the model, neither rate of change in PFCP nor EFCP from Time-
one to Time-four remained significant (PFCP: β= -0.12, t= -1.68, p=0.10, df=252; 
EFCP: β= -0.08, t= -1.16, p=0.25, df=252).  As the CES-D was not included at baseline, 
the baseline values for the CDI were used in the regression model to control for baseline 
symptoms of depression.   
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Predictor Variable 
Table 20:  Multiple Regression Analysis Examining the Impact of rate of 
change of Pain Self-Efficacy on Symptoms of Depression (CES-D) at 
Follow-up.   
Β T R2 change 
Step 1:  Predictor Variables   0.08*** 
     CDI sum at Time 1 0.29 4.80***  
Step 2:     0.02* 
     CDI sum at Time 1 0.32 5.25***  
     Slope of change in PFCP Time 1 to Time 4 -0.15 -2.46*  
*p<.05                                  **p<.01    
*** p<.001                           df=252    
 
 
Predictor Variable 
Table 21:  Multiple Regression Analysis Examining the Impact of rate of 
change of EFCP on Symptoms of Depression (CES-D) at Follow-up.   
Β T R2 change 
Step 1:  Predictor Variables   0.08*** 
     CDI sum at Time 1 0.29 4.80***  
Step 2:     0.02* 
     CDI sum at Time 1 0.34 5.28***  
     Slope of change in EFCP Time 1 to Time 4 -0.14 -2.13*  
*p<.05                                  **p<.01    
*** p<.001                           df=252    
 
 
In a separate analysis, neither initial levels of PFCP or EFCP were predictive of 
long-term CES-D (Table 22), indicating that it is the change in PFCP and EFCP, not the 
initial levels of pain-related self-efficacy that predict depressive symptoms at follow-up.   
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Predictor Variable 
Table 22:  Multiple Regression Analysis Examining the Impact initial levels 
of Pain-Related Self-Efficacy on Depressive Symptoms at Follow-up.   
Β T 
R2 
change 
Step 1:  Predictor Variables   0.09*** 
     CDI sum at Time 1 centered 0.29 4.83***  
Step 2:     0.001 
     CDI sum at Time 1 centered 0.30 4.36***  
     Time 1 PFCP centered  0.02 0.26  
     Time 1 EFCP centered 0.01 0.17  
*p<.05                                  **p<.01    
*** p<.001                           df=254    
          
 
Lower overall abdominal pain, as measured by the API, was significantly 
predicted by positive slope in PFCP between Time-one and Time-four both when it was 
entered alone and when entered with EFCP (Table 23).  The slope of EFCP between 
Time-one and Time-four was not predictive of overall pain when entered alone (β= -0.02, 
t= -0.32, p=0.75, df=235).  Additionally, none of the slopes between smaller time 
intervals predicted overall abdominal pain at follow-up.  Baseline API levels were 
controlled for in each analysis. 
 
Predictor Variable 
Table 23:  Multiple Regression Analysis Examining the Impact of rate and 
timing of change in Pain-Related Self-Efficacy on Abdominal Pain (API) at 
Follow-up.   
Β T R2 change 
Step 1:  Predictor Variables   0.04** 
     API at Time 1 centered 0.21 3.283**  
Step 2:     0.02 
     API at Time 1 centered  0.22 3.315**  
     Slope of change in PFCP Time 1 to Time 4 -0.15 -2.11*  
     Slope of change in EFCP Time 1 to Time 4 0.05 0.68  
*p<.05                                  **p<.01    
*** p<.001                           df=235    
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In a separate analysis, neither initial levels of PFCP or EFCP were predictive of 
long-term API (Table 24), indicating that it is the change in PFCP and EFCP, not the 
initial levels of pain-related self-efficacy that predict overall abdominal pain at follow-up.   
 
Predictor Variable 
Table 24:  Multiple Regression Analysis Examining the Impact initial levels 
of Pain-Related Self-Efficacy on Abdominal Pain at Follow-up.   
Β T 
R2 
change 
Step 1:  Predictor Variables   0.05** 
     API sum at Time 1 centered 0.22 3.49**  
Step 2:     0.01 
     API sum at Time 1 centered 0.20 2.87**  
     Time 1 PFCP centered  0.02 0.26  
     Time 1 EFCP centered -0.01 -1.22  
*p<.05                                  **p<.01    
*** p<.001                           df=244    
 
Somatic symptoms, as measured by the CSI, were significantly predicted by the 
rate of change in PFCP and EFCP from Time-one to Time-four, such that increases in 
pain-related self-efficacy predicted lower somatic symptoms both when entered 
separately and within the same analysis (Table 25).  When examining slopes between 
consecutive intervals in one analysis, slopes of change in PFCP were not predictive of 
long-term somatization (T1-T2 β= -0.24, t= -1.93, p=0.06, df=58; T2-T3 β= -0.19, t=-
1.41, p=0.16, df=58; T3-T4 β= 0.03, t=0.21, p=0.83, df=58).  However, the slope 
between Time-one and Time-two approached significance.  Each slope segment of EFCP 
was predictive of long-term somatization (Table 26).     
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Predictor Variable 
 Table 25:  Multiple Regression Analysis Examining the Impact of rate of 
change of Pain-Related Self-Efficacy on Somatic Symptoms (CSI) at 
Follow-up.   
Β T R2 change 
Step 1:  Predictor Variables   0.14*** 
     Somatic Symptoms at Time 1-centered 0.38 6.22***  
Step 2:     0.06*** 
     Somatic Symptoms at Time 1-centered 0.44 7.07***  
     Slope of change in PFCP Time 1 to Time 4 -0.14 -2.03*  
     Slope of change in EFCP Time 1 to Time 4 -0.16 -2.25*  
*p<.05                                  **p<.01    
*** p<.001                           df=234    
 
 
Predictor Variable 
Table 26:  Multiple Regression Analysis Examining the Impact of rate 
and timing of change of Emotion-Focused Coping Potential on Somatic 
Symptoms (CSI) at Follow-up.   
Β T 
R2 
change 
Step 1:  Predictor Variables   0.12** 
     Somatic Symptoms at Time 1-centered 0.35 2.774**  
Step 2:     0.14* 
     Somatic Symptoms at Time 1-centered 0.49 3.86***  
     Slope of change in EFCP Time 1 to Time 2 -0.33 -2.60*  
     Slope of change in EFCP Time 2 to Time 3 -0.29 -2.19*  
     Slope of change in EFCP Time 3 to Time 4 -0.26 -2.05*  
*p<.05                                  **p<.01    
*** p<.001                           df=58    
 
 
In a separate analysis, neither initial levels of PFCP or EFCP were predictive of 
long-term CSI (Table 27), indicating that it is the change in PFCP and EFCP, not the 
initial levels of pain-related self-efficacy that predict somatization at the long-term 
follow-up.   
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Predictor Variable 
Table 27:  Multiple Regression Analysis Examining the Impact initial levels 
of Pain-Related Self-Efficacy on Somatization at Follow-up.   
Β T 
R2 
change 
Step 1:  Predictor Variables   0.14*** 
     Somatic Symptoms at Time 1-centered 0.37 6.21***  
Step 2:     0.004 
     Somatic Symptoms at Time 1-centered 0.40 6.01***  
     Time 1 PFCP centered  0.03 0.39  
     Time 1 EFCP centered 0.05 0.69  
*p<.05                                  **p<.01    
*** p<.001                           df=240    
 
 
Lower Anxiety symptoms, as measured by the STAI, were significantly predicted 
by increases in PFCP between Time-one and Time-four but not by the slope of EFCP 
between Time-one and Time-four either when entered alone or when entered with the 
slope of PFCP (Table 28).  However, this increase in PFCP does not account for a 
significant amount of variance.  Analyses assessing where the change in PFCP was most 
influential showed that the slope between two-weeks and six-months was most predictive 
of anxiety symptoms as this slope was significantly predictive even with a relatively 
smaller sample size (Table 29), but it does not account for a significant amount of 
variance.  However, given the number of statistical tests run, the inclusion of participants 
only from the GICOPE study, and that the direction of the finding indicates increases in 
PFCP between T2 and T3 relate to increased Anxiety symptoms, it may be a spurious 
finding.  As symptoms of anxiety were not assessed at baseline, no baseline levels of 
anxiety were controlled in these regression models.  
 
 
67 
 
Predictor Variable 
  Table 28:  Multiple Regression Analysis Examining the Impact of rate 
of change of Pain-Related Coping Potential on Symptoms of Anxiety 
(STAI) at Follow-up.   
Β T 
R2 
change 
Step 1:  Predictor Variables   0.02 
     Slope of change in PFCP Time 1 to Time 4   -0.14 -2.01*  
     Slope of change in EFCP Time 1 to Time 4 0.04 0.55  
*p<0.05                   **p<0.01    
*** p<0.001              df=253    
 
 
Predictor Variable 
Table 29:  Multiple Regression Analysis Examining the Impact of rate and 
timing of change in PFCP on Symptoms of Anxiety (STAI) at Follow-up.   
Β T R2 change 
Step 1:  Predictor Variables   0..10 
     Slope of change in PFCP Time 1 to Time 2 -0.12 -0.96  
     Slope of change in PFCP Time 2 to Time 3 0.28 2.09*  
     Slope of change in PFCP Time 3 to Time 4 0.07 0.54  
*p<.05                                  **p<.01    
*** p<.001                           df=61    
 
 
In a separate analysis, neither initial levels of PFCP nor EFCP were predictive of 
Anxiety at the long-term follow-up (Table 30), indicating that it is the change in PFCP, 
not the initial levels of PFCP that predict anxiety at the long-term follow-up.   
 
Predictor Variable 
Table 30:  Multiple Regression Analysis Examining the Impact initial 
levels of Pain-Related Self-Efficacy on Anxiety at Follow-up.   
Β T R2 change 
Step 1:  Predictor Variables   0.02 
     Time 1 PFCP centered  -0.01 -0.18  
     Time 1 EFCP centered -0.11 -1.59  
*p<.05                                  **p<.01    
*** p<.001                           df=240    
68 
 
Using Binary Logistic Regression, the rate of change in PFCP between Time-one 
and Time-four did not significantly contribute to predicting whether a participant 
continued to have Chronic abdominal pain (CAP) or the CAP had resolved when it was 
entered in isolation (Wald=0.97, p=0.33, Exp(B)=0.37).  However, increases in EFCP 
significantly predicted a greater chance of the CAP being unresolved both when it was 
entered alone and when PFCP was included (Table 31).  Increases in PFCP predicted a 
greater likelihood of CAP being resolved when it was entered with the slope of EFCP.  
Consecutive PFCP slopes of smaller time intervals did not demonstrate significant ability 
to predict resolution.  However, when consecutive slopes of EFCP were included together 
in an analysis, it was later increases in EFCP that predicted unresolved CAP (Table 32).   
 
Predictor Variable 
Table 31:  Logistic Regression Analysis Examining the Impact of rate of change 
in Pain-related Self-efficacy on Resolution of CAP. 
B Wald Sig. Exp(B) 
Block 1:       
     Slope of change in PFCP Time 1 to Time 4 -3.31 7.19 0.01 0.04 
     Slope of change in EFCP Time 1 to Time 4 5.74 13.54 <0.001 310.20 
N=237;   Hosmer & Lemeshow p=0.52;   % correct=65.6 
 
 
Predictor Variable 
Table 32:  Logistic Regression Analysis Examining the Impact of the Timing of 
Change in Emotion-Focused Coping Potential on Resolution of CAP. 
B Wald Sig. Exp(B) 
Block 1:       
     Slope of change in EFCP Time 1 to Time 2 0.02 1.49 0.22 1.02 
     Slope of change in EFCP Time 2 to Time 3 0.31 2.60 0.11 1.37 
     Slope of change in EFCP Time 3 to Time 4 7.05 4.23 0.04 1152.04 
N=60;   Hosmer & Lemeshow p=0.32;   % correct=70 
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In an analysis including initial levels of PFCP and EFCP, higher initial levels of 
EFCP predicted the resolution of CAP (Table 33).  Thus, initially high EFCP is 
protective, but later decreases in EFCP and increases in PFCP predict resolution.  This 
pattern of increasing EFCP predicting unresolved CAP, especially later increases in 
EFCP, may reflect individuals’ accurate beliefs that the pain is not remitting, along with 
their increasing belief in their capacity to cope and function despite the pain.  Increasing 
PFCP predicting the resolution of CAP may reflect an accurate assessment in individuals’ 
reductions in symptoms.   
 
Predictor Variable 
Table 33:  Logistic Regression Analysis Examining the Impact of Initial levels 
of PFCP and EFCP on Resolution of CAP. 
B Wald Sig. Exp(B) 
Block 1:       
     Time 1 PFCP centered 0.05 0.11 0.74 1.05 
     Time 1 EFCP centered -0.55 12.08 0.001 0.58 
N=273;   Hosmer & Lemeshow p=0.80;   % correct=68.1 
 
 
  It was hypothesized that later changes in self-efficacy would have greater 
influence on outcomes.  The data from the current study did not bear this out except in 
respect to the resolution of CAP.  In predicting most outcomes, no particular time period 
of change was significant in and of itself; this may be due to smaller sample sizes because 
the smallest sample, only GICOPE, could be used to assess this question.  Rate of change 
in PFCP and EFCP also demonstrated a greater ability to predict psychological and 
functional outcomes than initial PFCP and EFCP levels. 
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CHAPTER IV 
 
DISCUSSION 
 
Primary findings:  Change in self-efficacy and relation to outcomes 
 The current study examined pain-related self-efficacy in patients with chronic 
pain with regard to its change over time and in relation to broad outcomes.  As predicted, 
in the current sample, the greatest change in pain-related self-efficacy occurred early on.  
After this initial increase, the rate of change tended to level out for both PFCP and EFCP.  
One explanation for this significant early change may be that seeing the 
gastroenterologist between the initial assessment and the two-week follow-up acted as an 
“intervention” for CAP patients.  The study did not evaluate or code the content of the 
appointments with the gastroenterologist, but it is likely that the patients and parents left 
the visit with a greater understanding of their pain and perhaps with a biopsychosocial 
understanding of the etiology and maintenance of their pain that enhanced both their 
PFCP and EFCP.  For instance, the clinician may have discussed the patient’s pain as real 
functional pain with biological sensitivities and psychological contributors such as stress, 
anxiety, and avoidance exacerbating the patient’s experience of pain.  The clinician may 
also have provided information including dietary advice that helped the patient to feel 
more efficacious.  Clinicians may have prescribed or recommended medications that led 
to some symptom alleviation, thereby enabling patients to feel more confident about 
being able to alleviate their pain and to feel more empowered to cope with their pain.  
While the exact mechanism by which this change occurred cannot be discerned from the 
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current data, the greatest increase in self-efficacy appeared to occur in relation to a shift 
following a visit to the gastroenterology clinic.     
It is noteworthy that even in the context of a sizeable initial change with gradual 
or non-significant change thereafter, it was the rate of change in pain-related self-
efficacy, rather than initial self-efficacy values, that predicted several long-term 
outcomes.  Particularly, increase in PFCP was strongly predictive of better physical and 
overall functioning and less abdominal pain at the long-term follow-up, somewhat 
predictive of fewer symptoms of depression and anxiety.  Patients showing greater 
increases in PFCP from baseline were also more likely to have experienced resolution of 
their CAP diagnosis.  Greater increase in EFCP was predictive of better physical 
functioning and less somatization, as well as somewhat predictive of fewer symptoms of 
depression.  Increase in EFCP over time actually predicted greater likelihood that one 
continues to experience unresolved CAP even though high initial levels of EFCP related 
to eventual resolution of CAP.  The finding that it is the ability to increase one’s sense of 
self-efficacy that predicted outcomes, rather than one’s initial self-efficacy level, may 
indicate that it is individuals’ abilities to utilize information and resources—such as those 
provided in the clinic visit—to increase their self-efficacy that matters more than these 
individuals’ reports of their self-efficacy beliefs prior to access to these resources.   
Only one prior study examining self-efficacy’s impact on functioning was 
longitudinal in design.  Thus, it is noteworthy that the results from this current 
longitudinal study did, to a large degree, parallel findings from cross-sectional and lagged 
design studies showing positive outcomes associated with increases in self-efficacy.  The 
current study found less consistent relation between self-efficacy and depressive 
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symptoms than prior research in children (Kaminsky, et al., 2006).  This may be because 
the prior cross-sectional finding reflected the relation between low self-worth and low 
belief in oneself when measured concurrently, whereas pain-related self-efficacy may be 
too domain specific to predict a purely psychological construct such as depressive 
symptoms several years later.  The relative lack of strength in EFCP predicting 
functioning parallels a prior study in children that did not find a relation between child 
reports of functional self-efficacy and physical functioning (Bursch, et al., 2006), but is 
inconsistent with the adult literature relating functional self-efficacy to physical 
functioning.  The difference in findings may be that the relation between these constructs 
differs in children and adults and the current study spans from childhood to young 
adulthood.  Additionally, the current study’s measure of functional self-efficacy—
EFCP—assessed beliefs about coping emotionally, whereas most measures of functional 
self-efficacy in the pain literature assess beliefs about one’s ability to perform tasks.  
Further clarification of the relative influence of functional self-efficacy—measured with 
both a focus on emotional coping and on ability to perform tasks—and pain self-efficacy 
across different developmental stages on psychological and physical functioning 
outcomes is needed.   
 
Factors influencing levels of self-efficacy 
Differences in gender influenced levels of self-efficacy across early time points.  
Females began with lower self-efficacy levels than males.  This parallels results from 
another study of initial levels of pain-related self-efficacy in children (Vierhaus, et al., 
2010) and is consistent with literature reporting lower self-efficacy levels for females 
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measured in non-pain domains (Larose, et al., 2006).  The current results also fit within 
the findings of a review in the adult pain-related self-efficacy literature (Chong, et al., 
2001) that found either higher self-efficacy reported by males or no gender differences.  
Prior pain research indicates that females experience more recurrent pain (Unruh, 1996), 
young girls exhibit more overt pain behaviors such as crying (Fearon, McGrath, & Achat, 
1996), and pain catastrophizing occurs more in females and mediates the relation 
between females reporting and exhibiting more pain (Keefe et al., 2000).  This suggests 
that females, on average, experience pain as more distressing and interfering than males, 
and behave in ways, such as crying, aimed at engendering the support of others.  One 
could surmise that these behaviors result from females’ relative lack of belief that they 
can manage or cope with pain independently; future studies are needed to test this 
relation directly.  In contrast to research findings in other non-pain domains (Larose, et 
al., 2006; McKellar, et al., 2008), the current study did not find significantly larger 
increases in self-efficacy for females, versus males, over time.  However, the lack of 
significant gender differences in self-efficacy ratings at later time points does imply 
females had somewhat greater increases in self-efficacy over time than did males, despite 
their slopes not being significantly different.        
 In the current study older children reported lower levels of PFCP across time 
points, but levels of EFCP were unrelated to age at any time point.  Self-efficacy theory 
proposes that contingencies, such as access to different supports, will vary by age 
(Cervone, et al., 2006) and will consequently influence levels of self-efficacy, but this 
was only partially supported by the current study.  However, the current study’s finding 
of no difference in age for EFCP, in particular, is consistent with a prior study of 
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functional self-efficacy in childhood that found no difference by age (Bursch, et al., 
2006).  Additionally, though one prior study (Chong, et al., 2001) of adults found lower 
pain-related self-efficacy in younger participants (17-35 year-olds), this finding does not 
contradict the current finding (i.e. higher levels PFCP in  younger participants) because 
of the differing age ranges across samples.  It may be that pain self-efficacy develops in a 
U shaped pattern such that values are initially higher in childhood, decrease in 
adolescence and emerging adulthood, then increase again in later adulthood; a study over 
the entire lifespan would help to clarify this.  Findings in the current study of lower levels 
of pain self-efficacy in adolescents parallels findings from other domains where 
functioning and well-being decrease during adolescence, such as increased rates of 
depression (Hankin & Abramson, 1999).  Relatively low self-efficacy during adolescence 
could also reflect adolescents’ feelings of uncertainty in themselves given they are likely 
engaging with the developmental task of identity formation and increased autonomy as 
they move through adolescence and emerging adulthood.  
While initial age influenced PFCP levels, initial age did not influence how 
predictive baseline self-efficacy levels were on long-term outcomes.  These findings did 
not support prior literature showing self-efficacy in older children is more predictive of 
behaviors (Davis-Kean, et al., 2008).  In general, initial age was not influential on self-
efficacy’s ability to predict outcomes, implying that it is just as useful to ask children 
about their self-efficacy as it is to ask adolescents, in terms of how this will affect their 
future functioning. 
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Relation between initial coping and disability and change in self-efficacy 
     Lower initial Passive coping related to greater increase in EFCP.  However, the 
hypothesis regarding initial Accommodative coping predicting increases in EFCP was not 
supported.  Both lower Passive and higher Accommodative coping predicted greater early 
increase in PFCP.  Less Passive coping likely allows one to engage in life and continue to 
function in valued ways despite the pain, consequently increasing functional self-
efficacy.  The fear-avoidance model of pain theorizes that individuals who appraise pain 
as a threat feel anxiety and apprehension about experiencing increased pain through 
activity and consequently avoid activity; this avoidance leads to disability (Asmundson & 
Wright, 2004).  Passive coping includes isolating oneself and avoidance of activities and 
this withdrawal from life and experiences likely confirms one’s belief that she cannot 
cope or function with pain and likely leads to real functional disability that further 
confirms one’s beliefs about not being able to function.  However, lower initial Passive 
coping also led to less increases in PFCP from the six-month to long-term follow-up and 
this may reflect individuals who initially engaged actively to reduce their pain but whose 
pain did not abate, thus they reported lower levels of PFCP at the long-term follow-up 
because, despite their best efforts, they could not alleviate pain.             
 Functioning and pain-related self-efficacy are strongly related throughout the 
literature (e.g. Arnstein, 2000; Ayre & Tyson, 2001; Buckelew, et al., 1995; Denison, et 
al., 2004; Estlander, et al., 1994; Kaivanto, et al., 1995), but the direction of causality is 
unclear given the lack of longitudinal studies.  The current study showed that functional 
impairment at baseline had little impact on changes in long-term PFCP.  Less initial 
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functional disability did predict early increases in EFCP.  This relation could indicate that 
less impairment acts as evidence that bolsters one’s confidence in coping and functioning 
with the demands of life despite the pain.  As noted earlier, results from the current study 
indicated that increases in both PFCP and EFCP predict less long-term functional 
disability.  Given initial functional disability’s relative lack of ability to predict changes 
in PFCP and functional disability’s limited ability to predict only early changes in EFCP, 
it is likely that self-efficacy influences disability, rather than disability influencing pain-
related self-efficacy.        
 
Overview 
In summary, several overall patterns regarding changes in self-efficacy emerge 
from the current study.  Without specific intervention, the largest increases in pain-related 
self-efficacy occurred early after a clinic visit.  Differences in the rate of change in PFCP 
and EFCP, rather than initial values, predicted several important long-term outcomes.  
Self-reports of both children and adolescents’ pain-related self-efficacy are likely to be 
equally informative about their later physical and psychological functioning while initial 
differences in gender and age can provide some insight into differences in pain-related 
self-efficacy reports at baseline.  Finally, baseline coping strategies, particularly Passive 
coping, influenced patterns of change in self-efficacy among individuals diagnosed with 
CAP.   
Broadly speaking, the patterns of change were similar for PFCP and EFCP.  
However, there are some noteworthy differences between the two constructs both in their 
pattern of change and in their utility in predicting outcomes.  In the current study, PFCP 
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was the more consistent predictor of outcomes, though both have some predictive utility.  
These differences speak to the value of retaining pain self-efficacy and functional self-
efficacy as distinct constructs under the broader construct of pain-related self-efficacy.  
This is particularly true given the larger self-efficacy literature’s emphasis on specificity 
in self-efficacy (DeVellis & DeVellis, 2001), such that more precise and distinct 
definitions are valued.  Additionally, within the pain-related self-efficacy literature, these 
two constructs are distinct and are frequently not examined within the same study.  Most 
of the studies examining the relation between pain-related self-efficacy and functioning 
in the context of pain assess functional self-efficacy rather than pain self-efficacy (e.g., 
Chong, et al., 2001; Estlander, et al., 1994; Kaivanto, et al., 1995; Nicholas, 2007); thus 
the current findings speak to the need to increasingly include pain self-efficacy, not only 
functional self-efficacy, in pain research. 
 
Clinical Implications 
As self-efficacy levels did predict several improved functional outcomes, there is 
likely utility in interventions aimed at increasing pain-related self-efficacy.  Marks (2001) 
reviewed the literature on interventions aimed at improving the management of arthritis 
and observed that interventions can increase self-efficacy.  Given that self-efficacy can be 
manipulated, it is important to understand the natural variations and course of change in 
self-efficacy in order to understand how, when, and with whom interventions should be 
aimed.  One study in the review conducted by Marks (2001) found interventions resulted 
in changes in only pain self-efficacy and not functional self efficacy; however, most 
studies found changes occurred in overall self-efficacy.  In the current study, growth in 
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PFCP (i.e., pain self-efficacy) was most predictive of long-term outcomes amongst 
patients with a wide range of initial pain and disability levels.  These results suggest that 
interventions aimed at increasing strategies for increasing one’s sense of ability to control 
and reduce pain would have the greatest impact on long-term outcomes.     
In the current sample, the greatest increase in both PFCP and EFCP occurred 
within the first two-weeks following the initial clinic visit.  Thus, a follow-up 
appointment with a mental health clinician shortly after a patient’s initial 
gastroenterology appointment would likely be the best time to evaluate whether the 
appointment itself improved the patient’s self-efficacy, or whether additional intervention 
targeting self-efficacy is needed.  It may be helpful to assess self-efficacy prior to the 
initial clinic visit and then two-weeks later to determine if there are changes between that 
initial visit and the two-week assessment, given change is more predictive of outcomes 
than initial self-efficacy level.  Thus, individuals who do not show much natural increase 
between these two time points may be those most in need of intervention.   
On the whole, the initial clinic visit in the current study appeared to function as an 
intervention given the significant and largest increase in self-efficacy from Time-one to 
Time-two.  Further research assessing what typically is addressed in a clinic visit and 
which components most strongly contribute to growth in self-efficacy could be helpful in 
disseminating helpful strategies to other clinics and emphasizing these points in visits.  
Health psychologists working in an integrative clinic could meet with the patient on the 
first clinic visit and provide psychoeducation about the biopsychosocial model of pain as 
well as introduce beneficial coping strategies.  This early and brief psychological 
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intervention could help to minimize harmful strategies like avoidance and Passive coping 
and hopefully maximize the gains in self-efficacy provided by the clinic visit.      
Females likely have greater need and may benefit more from interventions aimed 
at increasing self-efficacy given their relatively low initial levels of self-efficacy and 
failure to show significant compensatory increases thereafter.  Socialization may 
encourage females to express their pain more than males and they also may learn to rely 
more heavily on the aide of caregivers (Fearon, et al., 1996; Keefe, et al., 2000) rather 
than to have confidence in their own ability to cope with pain.  Interventions with females 
could focus on building females’ abilities to use resources such as social support in ways 
that build on their own capacities.  Helping females to see their power and control, even 
while using outside supports, may build females’ self-efficacy.       
Results of the current study indicated that older children and adolescents might 
need more intervention to increase their pain self-efficacy than do younger children.  This 
may be related to older patients being more likely than younger children to initiate the 
doctor visit, perhaps reflecting their feeling more distressed or hopeless about their pain 
and ability to alleviate or function with their pain.  Additionally, as depression rates are 
higher in adolescents than in younger children (Hankin & Abramson, 1999) it may be 
that adolescents have a more negativistic view of their world.  In this case, using 
Cognitive Behavioral skills to enhance overall sense of control and feelings of self-worth 
may be beneficial.  However, this pattern of older patients reporting lower self-efficacy 
continues across time points and into adulthood and does not appear to end in 
adolescence.  Further research directed at understanding the cause underlying these 
developmental differences in self-efficacy ratings would help to best direct interventions.      
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The pain literature suggests that individuals who report high Passive coping are 
likely to have poorer psychological and physical functioning (Smith, Wallston, Dwyer, & 
Dowdy, 1997; L. S. Walker, et al., 1997).  The current study demonstrates they are likely 
to have less growth in pain–related self-efficacy as well.  Interventions that increase 
patients’ number of Accommodative and Active coping strategies to replace maladaptive 
coping strategies are likely to increase self-efficacy levels and may improve other areas 
of functioning as well.  Increasing individual’s engagement with the world and with 
valued activities will help to interrupt the pain cycle by decreasing avoidance 
(Asmundson & Wright, 2004) and will likely help individuals to experience less pain and 
feel more efficacious for coping with any pain that does occur.         
Depending on the outcome of interest, interventions may differentially emphasize 
pain or functional self-efficacy.  Based on the findings from this study, interventions 
aimed at decreasing or preventing depressive symptoms should likely focus on increasing 
both pain self-efficacy and functional self-efficacy.  Similarly, those aimed at increasing 
physical functioning should likely equally emphasize increasing pain self-efficacy and 
functional self-efficacy.  Interventions aimed at reducing anxiety or at decreasing pain 
should focus primarily on improving pain self-efficacy.  In contrast, somatization is likely 
to be reduced most by focusing on increasing functional self-efficacy.  However, it 
should be noted that the current study examined the influence of natural increases in pain-
related self-efficacy and increases based on interventions may have different influences 
on outcomes. 
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Limitations and Future Directions  
 There is disagreement about whether self-efficacy can be assessed only in regard 
to very precise and specific tasks (DeVellis & DeVellis, 2001) or whether it can be 
assessed with a more generalized total score (Levin, et al., 1996) as we have done in the 
above study.  Thus, there are those who would argue that what this study labeled self-
efficacy is not in fact self-efficacy.  Additionally, since the initiation of the initial data 
collection, Bursch, Tsao et al. (2006) have published  a more specific child pain self-
efficacy questionnaire focused on a more traditional definition of functional self-efficacy. 
Their measure assesses beliefs about one’s ability to perform specific tasks while in pain, 
rather than beliefs about one’s ability to cope emotionally with having pain as in the 
PBQ.  However, Bursch’s measure does not assess beliefs in one’s ability to alleviate 
pain and no other measure exists to assess self-efficacy for pain alleviation in children.  It 
would be interesting to conduct similar research with Bursch’s pain self-efficacy measure 
and see if the results are comparable with the current study. 
 The extreme unevenness in the time intervals in the current study posed analytical 
difficulties even though HLM is flexible in terms of dealing with missing data points and 
variety in the length of time between assessments (Singer & Willett, 2003).  The intervals 
between time points varied from 2-weeks to 15-years, making examination of non-linear 
changes using HLM difficult because one would need to assume the chosen arc of the 
nonlinear curve from six-months to long-term follow-up was accurate, though it was 
based on only a few data points very far from the long-term follow-up.  Thus, the current 
study did not examine changes across more than two time points when using HLM; 
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however, it represents a significant step forward in our understanding of self-efficacy in 
CAP, particularly given the dearth of prospective studies on outcomes of CAP.  Future 
research with more frequent assessments and reduced variability in the intervals between 
them would enable exploration of non-linear patterns of change. 
 The reviewed literature examined a variety of pain conditions including 
functional, organic, and pain of unclear etiology.  The current study examined one 
specific type of pain condition (i.e. CAP) and it is unclear whether the findings in this 
study would generalize to other pain conditions, particularly those with a stronger organic 
component to their etiology.  However, while this may limit this study’s generalizability, 
it is also a strength of the current study in that there is a relatively homogeneous pain 
population to which these findings pertain.  As such, variability in etiology is unlikely to 
explain null findings, findings counter to a priori hypothesis, or reports in past literature.     
 The sample was comprised primarily of Caucasians and, while representative of 
the general CAP population and those seeking treatment at this tertiary care center 
specifically, the lack of ethnic diversity does limit generalizability.  Additionally, this 
study was conducted at one site in the Southern United States and may not be 
representative of the development and impact of pain-related self-efficacy in the greater 
United States or the world.  Different strategies or mentalities may be more beneficial to 
improved outcomes in other cultures including those that are less individualistic or have 
different typical daily demands on individuals.   
 Finally, the current study is limited by the lack of assessments related to 
mechanisms by which self-efficacy improved in individuals.  For example, the current 
study did not assess whether the patients participated in any treatment or interventions to 
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address their CAP symptoms.  Individuals may have attended psychotherapy, taken 
medications, or pursued alternative therapies in an attempt to alleviate or cope with pain, 
but these attempts were not recorded and thus, were not included in any analyses.  Future 
research examining the impact of interventions, either randomly assigned or individually 
chosen as well as those specifically aimed at self-efficacy or generally pain related would 
be beneficial.     
 The current study supports a growing literature that pain-related self-efficacy is an 
important positive psychological construct for protecting and aiding those with chronic 
pain conditions.  It adds to a developmental understanding of changes in self-efficacy, 
demonstrating that younger and older children’s self-efficacy can influence both 
psychological and physical long-term functioning and that the self-reported self-efficacy 
of children as young as eight years old has predictive validity.  Older children may be 
those who are in most need of interventions aimed at increasing pain-related self-
efficacy.  Females are also a subset of CAP patients with an increased need of 
intervention given their lower pain-related self-efficacy levels across development and 
time.  Further research is needed examining whether interventions aimed at increasing 
pain self-efficacy actually influence reported levels and lead to improved outcomes.  
Additionally, more research across even wider developmental time frames and with more 
frequent assessment would be helpful to elucidate developmental patterns, particularly if 
the patterns of change are non-linear as the results of this study and Chong (2001) taken 
together may suggest.        
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APPENDIX I   
 
Study Measures 
 
Pain Beliefs Questionnaire—Self-Report Version 
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PRI 
 
 
 
 
87 
 
 
 
 
 
88 
 
89 
 
FDI—Adult 
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SF-36 Health Survey 
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CSI 
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Rome III Modular Questionnaire 
 
Now, I would like to ask you some questions about health problems that adults 
sometimes have with their stomach and intestines. 
 
1. ***In the last 3 months, how often did you have discomfort or pain anywhere in your abdomen? 
  0. Never------------------------->SKIP TO QUESTION 10 
  1. Less than one day a month 
  2. One day a month 
  3. Two to three days a month 
  4. One day a week 
  5. More than one day a week 
  6. Every day 
 
2. For women only:  Did this discomfort or pain occur only during your menstrual bleeding and not at other times?   
  0. No           1. Yes           2. Does not apply 
 
3. When you had this pain, how often did it limit or restrict your daily activities (for example, work, household 
activities, and  
social events)? 
  0. Never or rarely (0 % of the time) 
  1. Sometimes (25 % of the time) 
  2. Often (50 % of the time) 
  3. Most of the time (75 % of the time) 
  4. Always (100 % of the time) 
 
4. How long have you had this discomfort or pain? 
  0. Less than 2 months 
  1. 2 months 
  2. 3-5 months 
  3. 6 months or longer 
 
5. How often did this discomfort or pain get better or stop after you had a bowel movement? 
  0. Never or rarely (0 % of the time) 
  1. Sometimes (25 % of the time) 
  2. Often (50 % of the time) 
  3. Most of the time (75 % of the time) 
  4. Always (100 % of the time) 
 
When this discomfort or pain started, 
how often… 
Never 
0 % 
Sometimes 
25 % 
Often 
50 % 
Most of the time 
75 % 
Always 
100% 
6.  Did you have more frequent bowel 
movements? 0 1 2 3 4 
7.  Did you have less frequent bowel 
movements? 0 1 2 3 4 
8.  Were your stools (bowel 
movements) looser? 0 1 2 3 4 
 9.  Did you have harder stools? 
 0 1 2 3 4 
 
10. ***In the last 3 months, how often did you have pain or burning in the middle of your abdomen, above your belly 
button but not in your chest? 
  0. Never------------------------->SKIP TO QUESTION 12 
  1. Less than one day a month 
  2. One day a month 
  3. Two to three days a month 
  4. One day a week 
  5. More than one day a week 
  6. Every day 
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11. How long have you had this pain or burning? 
  0. Less than 2 months 
  1. 2 months 
  2. 3-5 months 
  3. 6 months or longer 
 
12. ***In the last 3 months, how often did you feel uncomfortably full after a regular-sized meal? 
  0. Never------------------------->SKIP TO QUESTION 14 
  1. Less than one day a month 
  2. One day a month 
  3. Two to three days a month 
  4. One day a week 
  5. More than one day a week 
  6. Every day 
 
13. How long have you had this uncomfortable fullness after meals? 
  0. Less than 2 months 
  1. 2 months 
  2. 3-5 months 
  3. 6 months or longer 
  
14. ***In the last 3 months how often were you unable to finish a regular-sized meal? 
  0. Never------------------------->SKIP TO QUESTION 16 
  1. Less than one day a month 
  2. One day a month 
  3. Two to three days a month 
  4. One day a week 
  5. More than one day a week 
  6. Every day 
 
15. How long have you had this inability to finish regular-sized meals? 
  0. Less than 2 months 
  1. 2 months 
  2. 3-5 months 
  3. 6 months or longer 
 
In the last 3 months,  
how often… 
Never 
0 % 
Sometimes 
25 % 
Often 
50 % 
Most of the time 
75 % 
Always 
100% 
16.  ***Did you have fewer than three 
bowel movements (0-2) a week? 0 1 2 3 4 
17.  Did you have hard or lumpy 
stools? 0 1 2 3 4 
18.  Did you have 4 or more bowel 
movements a day? 0 1 2 3 4 
19.  Did you have loose, mushy or 
watery stools? 0 1 2 3 4 
20.  Did you have to rush to the toilet 
to have a bowel movement? 0 1 2 3 4 
 
21. In the last 3 months, how often did you feel bloated in your abdomen? 
  0. Never 
  1. Less than one day a month 
  2. One day a month 
  3. Two to three days a month 
  4. One day a week 
  5. More than one day a week 
  6. Every day 
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22. ***In the last year, how many times did you have an episode of severe intense pain around the belly button 
that lasted 2 hours or longer and made you stop everything that you were doing? 
  0.  Never-------------->End Rome III Q 
  1.  1 time      
  2.  2 times 
  3.  3 to 5 times 
  4.  6 or more times 
 
23.  During the episode of severe intense pain did you have…? 0. No 1. Yes 
a. No appetite?   
b. Feeling sick to your stomach?   
c. Vomiting (throwing up)?   
d. Pale skin?   
e. Headache?   
f. Eyes sensitive to light?   
 
24. Between episodes of severe intense pain, do you return to your usual health for several weeks or longer? 
  0. No           1. Yes 
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STAI Form Y-2 
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API 
 
Self-Report Version 
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Children’s Depression Inventory 
 
 
 
101 
 
 
102 
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Center for Epidemiologic Studies Depression Scale 
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